4 -- chapter 1 pharmacology for technicians
TRANSCRIPT
11
Upon completion of Chapter 1, the pharmacy technician student will be able to 1. Listanddescribethevarioussystemsofthehumanbodyandtheirfunction. 2. Definethetermspharmacology, pharmacokinetics,andtherapeutic equivalence. 3. Discusstheimportanceofrecognizingdruginteractions,problems,andpregnancycategories. 4. Recognizeandrecallhowdrugnamesarecreatedandhowtheirnamescanindicateusage. 5. Recognizethefollowingforeachdrugclassificationandmedication:
• Mechanismofaction• Medicationswithineachclassification• Differencebetweeneachclassification• Brandandgenericname• Thedailydosage,dosageforms,androuteofadministration• Commonsideeffects,allergicreactions,andtherapeuticcontraindications
6. Identifycommonvitamins,electrolytes,nutritionalsupplements,minerals,andover-the-countermedications.
1Chapter
Pharmacology for Technicians
2.1 Drugclassification2.1.1 Majordrugclasses(e.g.,analgesics,anes-
thetics,antibiotics)2.1.2 Dosageforms(types,characteristics,and
uses)2.1.3 Over-the-counterproducts
2.2 Mostfrequentlyprescribedmedications2.2.1 Brandandgenericnames2.2.2 Basic mechanism of action (pharmacol-
ogy)anddrugclassification2.2.3 Primaryindications2.2.4 Common adverse drug interactions and
contraindications
ExCPT Knowledge Domains
1.1 Genericandbrandnamesofpharmaceuticals1.2 Therapeuticequivalence1.3 Druginteractions(e.g.,drug–disease,drug–drug,
drug–dietary supplement, drug–over-the-counter[OTC]drug,drug–laboratory,drug–nutrient)
1.4 Strengthsanddoses,dosageforms,physicalap-pearance, routesof administration, anddurationofdrugtherapy
1.5 Common and severe side or adverse effects,allergies,andtherapeuticcontraindicationsasso-ciatedwithmedications
1.6 Dosage and indication of legend, OTC medica-tions,herbalanddietarysupplements
PTCB Knowledge Domains
ChapterObjectives
12 Mosby’s Review for the Pharmacy Technician Certification Examination
CARDIOVASCULAR SYSTEM• Theheartisamusclethatinitiatessystemicarterial
pulsewaves,causingbloodtocirculatethroughoutthebodyandsupplyitwithnutritionandoxygen.Consists of the heart (pumps blood that supplies
nutrientsandoxygenthroughoutthebody),arter-ies(carriesoxygenatedbloodandnutrientstothetissues and organs), veins (returns deoxygenatedbloodtotheheart),andcapillaries.
ANATOMY OF THE EAR EAR COMPONENT FUNCTION
External EarAuricle ServesasentranceforsoundintotheearAuditorycanal LinkstheexternaleartothetympanicmembraneTympanicmembrane Protectsmiddleearfromforeignobjectsandtransmitssoundwavestothemiddleear
Middle EarMalleus(hammer) TransmitssoundwavesIncus(anvil) TransmitssoundwavesStapes(stirrup) TransmitssoundwavesEustachiantube Connectsmiddleeartothenasopharynx;relievesthechangeofpressurebetween
theoutsideandinsideoftheearduringswallowingoryawning
Inner EarLabyrinth TransmitsaudiblesoundsvianerveimpulsesCochlea TransmitsimpulsestothebrainVestibule ResponsibleforequilibriumandbalanceSemicircularcanal Transferofmessageviaacousticnerve
ANATOMY OF THE CARDIOVASCULAR SYSTEM FUNCTION
Aorta Thelargestarteryinthebody,originatingfromtheleftventricleoftheheartandextendingdowntotheabdomen;theaortadistributesoxygenatedbloodtoallpartsofthebodythroughthesystemiccirculation
Endocardium InnerlayeroftheheartwallthatallowstheheartwalltocollapsewhenitcontractsMyocardium MiddlelayeroftheheartwallthatcontractsEpicardium OuterlayeroftheheartwallSuperiorvenacava TransportsvenousbloodfromtheupperportionofthebodytotheheartInferiorvenacava TransportsvenousbloodfromthelowerportionofthebodytotheheartRightventricle ExpelsbloodthroughthepulmonaryarteriestothelungsLeftatrium ReceivesoxygenatedbloodfromthelungsLeftventricle ContractsandexpelsoxygenatedbloodintotheaortaRightatrium Receivesbloodfromthebody
ANATOMY AND PHYSIOLOGY
AUDITORY SYSTEM
• Responsibleforhearing,balance,equilibrium,andcommunicationskills
Chapter 1 Pharmacology for Technicians 13
ENDOCRINE SYSTEM• Responsible for the production and secretion of
hormonesfromtheglands• Hormonesstimulatespecifictargetcells,resulting
inaresponse
• Includes the pituitary gland, hypothalamus, pi-neal gland, thyroid gland, parathyroid gland,thymus, adrenal gland, pancreas, ovaries, andtestes
DIGESTIVE SYSTEM• Responsibleforthedigestion,absorption,metabo-
lism,andexcretion(elimination)offood
ANATOMY OF THE DIGESTIVE SYSTEM FUNCTION
Gallbladder SmallorganthataidsmainlyinfatdigestionandconcentratesbileproducedbytheliverMouth ChewsfoodSalivarygland SecretestheenzymeamylaseusedtobreakdowncarbohydratesPharynx ConnectsthemouthtotheesophagusEsophagus TransportsfoodfromthemouthtothestomachPancreas Bothanendocrineglandproducingseveralimportanthormones,includinginsulin,gluca-
gon,somatostatin,andpancreaticpolypeptide,andadigestiveorgan,secretingpancre-aticjuicecontainingdigestiveenzymesthatassisttheabsorptionofnutrientsandthedigestioninthesmallintestine
Stomach ReleasesacidtobreakdownfoodSmallintestine AbsorbsnutrientsfromdigestedfoodLargeintestine Reabsorbswaterbackintobody;excretesoreliminatesfoodfromthebodyRectum Excretesfecalmatterfromthebody
ANATOMY OF THE ENDOCRINE SYSTEM FUNCTION
Pituitarygland TheanteriorpituitaryglandproducesGH,TSH,ACTH,FSH,LH,andprolactin;theposteriorpituitaryglandproducesoxytocinandvasopressin(ADH)
Hypothalamus ServesasabridgebetweenthenervoussystemandthehormonalsystemPinealgland Maintainscircadianrhythmsandsleep–awakepatternsThyroidgland Producesthyroxine(T4),triiodothyronine(T3),andcalcitoninParathyroidgland SecretesPTH,whichmaintainsappropriatecalciumlevelsinthebodyThymusgland SecreteshumoralfactorsnecessaryinmaintainingtheimmunesystemAdrenalgland Themedullaregionsecretesepinephrineandnorepinephrine;thecortexregionsecretes
glucorticoidandmineralocorticoidhormonesPancreas ProducesandsecreteshormonesfromtheisletsofLangerhans;alphacellsproduce
glucagon,andbetacellsproduceinsulinOvaries(females) SecreteestrogenandprogesteroneTestes(males) Secretetestosterone
ACTH,Adrenocorticotropichormone;ADH,antidiuretichormone;FSH,follicle-stimulatinghormone;GH,growthhormone;LH,luteinizinghormone;PTH, parathyroidhormone;TSH,thyroid-stimulatinghormone.
• Organsofthedigestivesystemincludethemouth,salivary glands, pharynx, esophagus, stomach,smallintestine,largeintestine,andrectalarea
IMMUNE SYSTEM• Adefensesystemthatidentifiesanddestroysfor-
eignsubstancesthatinvadethebody
ANATOMY OF THE IMMUNE SYSTEM FUNCTION
Thymus Asmallglandularorganthatissituatedbehindthetopofthebreastbone,consistingmainlyoflymphatictissueandservingasthesiteofT-celldifferentiation
Lymphnode Filtersfluids,catchingviruses,bacteria,andotherunknownmaterialsTcells WBCsknownaslymphocytesandplayacentralroleincell-mediatedimmunityBcells Makeantibodiesagainstantigens,toperformtheroleofAPCs,andtodevelopintomemory
BcellsafteractivationbyantigeninteractionSpleen Actsasabloodfilter
APC, Antigen-presentingcell;WBC, whitebloodcell.
14 Mosby’s Review for the Pharmacy Technician Certification Examination
INTEGUMENTARY SYSTEM• Protects the body against heat, cold, light, dehy-
dration,andinfection
ANATOMY OF THE SKIN FUNCTION
Epidermis ProducesnewskincellsDermis Containscollagenandsupportsbloodvessels,glands,andnervesSC(hypodermis) StoresfatthatinsulatesthebodySebaceousglands SecretessebumthatlubricatestheskinandretainswatertokeephairandskinsoftSweatglands Actsascoolingsystemwhenthebodytemperaturerises
NERVOUS SYSTEM• Controls both voluntary and involuntary func-
tionsofthebody• Responsibleforthetransmissionofimpulsesfrom
sensory neurons to the central nervous system(CNS);interpretationofimpulsessenttotheCNSand transmission of a response to muscles or
glands; coordination of the activities of all divi-sionsof thenervoussystem;andmaintenanceofhomeostasisbyrespondingtosensorychangesinthebody.
• Consistsoftwocomponents,theCNSandperiph-eralnervoussystem(PNS)
ANATOMY FUNCTION
Cerebral CortexFrontallobe Controlsmotorfunction,partsofspeech,emotions,problemsolving,reasoning,andplanningParietallobe Responsiblefororientation,recognition,sensation,andcomprehendinglanguageOccipitallobe ControlsperceptionandinterpretationrelatedtovisionTemporallobe Responsibleforauditorystimuli,long-termmemory,andbehavior
BrainstemMidbrain Responsibleforvision,hearing,eyemovement,andvoluntarybodymovementPons AccountableformotorcontrolandsensoryanalysisMedullaoblongata Inchargeofbreathing,cardiacrate,heartcontractions,andbloodvesseldilation
DiencephalonThalamus ResponsiblefortransmittingmessagesbetweenthebrainspinalcordandforbodytemperaturecontrolHypothalamus Controlsemotions,thirst,hunger,heartrate,andautonomicnervoussystemhormoneproduction
CerebellumCerebellum Maintainsbodybalance,posture,andcoordinatingmovement
Cranial NervesI OlfactoryII OpticIII SpecificeyeandeyelidmovementIV AnotherspecifictypeofeyemovementV Providessensationtotheface,scalp,mucousmembranesinthenose,mouth,andeyesVI EyemovementVII TasteinthefrontofthetongueVIII InnerearhearingandbalanceIX ReflexcontrolofheartandswallowingX Swallowing,breathing,speaking,heartbeat,anddigestionXI Swallowingandmovementthroughthedigestivetract;musclemovementsoftheuppershoulders,head,
andneckXII Tonguemuscles
Blood–Brain BarrierBlood–brainbarrier Preventsmoleculesfromenteringanddamagingthebrainbyachemicalreaction
CENTRAL NERVOUS SYSTEM
Chapter 1 Pharmacology for Technicians 15
• The spinal cord is a pathway from the brain tothePNS.
REPRODUCTIVE SYSTEM• Productionofoffspringforthesurvivalofthespecies
SYSTEM ANATOMY FUNCTION
Autonomicnervoussystem
Sympatheticsystem
Parasympatheticsystem
Responsibleforunconsciousbodyfunctionssuchastheheartbeatandbreathing
Respondsinstressfultimeandshutsdownnonessentialsystemsduringa“fight-or-flight”situation
CounterbalancesthesympatheticsystemSomaticsystem Sendsmotorimpulsestotheskeletalmuscle
PERIPHERAL NERVOUS SYSTEM
OPHTHALMIC SYSTEM• Responsibleforprovidinganindividualwithvision
ANATOMY OF THE EYE FUNCTION
Orbit SocketthatcontainstheeyeConjunctiva AthintransparentmucousmembranethatcoverstheanterioreyeSclera ProtectivewhiteportionofeyethatcontainsfibersandmusclesIris ResponsibleforthecoloroftheeyeandfilterslightCornea AllowslightintotheeyeforvisualacuityPupil AllowstheproperamountoflighttoentertheeyeLens FocusestheimageRetina ContainsreceptorcellsthatareresponsibleforvisionLacrimalgland SecretestearsthatpossessantimicrobialenzymesOpticnerve Sendsimagesfromtheeyetothebrain
MALE REPRODUCTIVE STRUCTURES FUNCTION
Testicles ProductionandimmediatestorageofspermEpididymis ResponsibleforthestorageofmaturespermcellsProstate SecretesfluidnecessaryforthetransportofspermcellsUrethra Transportspermcellsandfluidforejaculationduringsexualintercourse
MALE REPRODUCTIVE SYSTEM
ANATOMY FUNCTION
Ovary ProducesovaFallopiantube TransportstheovamonthlywhereitmaybecomefertilizedUterus HousesthefertilizedeggMammaryglands UsedduringmilkproductionEndometrium Functionsasaliningfortheuterus,preventingadhesionsbetweentheopposedwallsofthemyometriumCervix Duringmenstruation,thecervixstretchesopenslightlytoallowtheendometriumtobeshedVagina Hastwomainfunctions,sexualintercourseandchildbirth
FEMALE REPRODUCTIVE SYSTEM
16 Mosby’s Review for the Pharmacy Technician Certification Examination
RESPIRATORY SYSTEM• Responsible for respiration and maintaining
homeostasis
THERAPEUTIC EQUIVALENCE
Adrugisdefinedasbeingtherapeuticallyequivalentifthedrug:• Containsthesamechemicalentity• Containsthesamequantityofactiveingredient• Isthesamedosageform• Hasthesamerouteofadministration
RESPIRATORY SYSTEM ANATOMY FUNCTION
Upper Respiratory SystemNoseNasalcavitiesCiliaPharynxLarynx
DetectssmellandservesasadrainagesystemfortearsfromtheeyesWarmsandmoistensinhaledairCatchsmallairparticlesTubethatissharedwiththedigestivesystemContainsthevocalcordsthatproducesound
Lower Respiratory SystemAlveolusTracheaBronchialtreeLungs
Siteofgas(oxygenandcarbondioxideexchange)Trapsparticlesandexpelsthem;providesapathwaytothelungsProvidesoxygendistributionandservesasapassagewaytothealveoliPromotesbreathing,whichincludesinspirationandexpiration
URINARY SYSTEM• Responsible for the excretion of chemicals and
substancesfromthebodysystem• Responsibleforcreatingandmaintaininghomeo-
stasisthroughoutthebody
• Maintainingchemicalcompositionofelectrolytes,fluids,andtissuesthroughoutthebody
• Preservingnormalbloodpressure• Productionerythropoietin
• Consists of two systems, the upper and lowerrespiratorysystem
ORGAN ANATOMY FUNCTION
KidneyUreter Carrieswasteproductsremovedfromthebloodtothebladder;carrieswastefromthe
kidneystothebladderBladder WasteproductsarestoredatthislocationuntileliminatedUrethra CarrieswasteproductsfromthebodyNephrons Responsiblefortheregulationoffluids,solutes,andwasteRenalartery CarriesbloodintothekidneyNephron Chieffunctionistoregulatetheconcentrationofwaterandsolublesubstancessuchassodium
saltsbyfilteringtheblood,reabsorbingwhatisneeded,andexcretingtherestasurineLoopofHenle Createsaconcentrationgradientinthemedullaofthekidney
PHARMACOLOGY
Pharmacologyisdefinedasthescientificstudyoftheactionofdrugsonalivingsystem.Amedicationinter-actswithreceptorsandproducesabiologicalresponse.
PHARMACOKINETICS
Pharmacokinetics involves the absorption, distribu-tion,metabolism,andelimination (excretion)of thedruginalivingsystem.
Chapter 1 Pharmacology for Technicians 17
INTERACTIONS
DRUG–DRUG INTERACTIONS
Onedrugalters theactionofanotherdrug; interac-tionsincludeaddition,antagonism,potentiation,andsynergism.• Addition:Thecombinedeffectoftwodrugs;itis
equaltothesumoftheeffectsofeachdrugtakenalone.
• Antagonism: One drug works against the actionofanotherdrug.
• Potentiation:Onedrugincreasesorprolongstheeffect of another drug; the total effect is greaterthanthesumoftheeffectsofeachdrugalone(e.g.,VistarilandDemerol).
• Synergism: The joint action of drugs in whichtheircombinedeffectismoreintenseorlongerindurationthanthesumoftheeffectsoftwodrugs
DRUG–DISEASE INTERACTIONSVariousdiseasesmayinhibittheabsorption,metabo-lism,andeliminationofdifferentdrugs.Anexampleistakingdecongestantsifthepatientishashyperten-sionordiabetes.
DRUG–DIETARY SUPPLEMENT INTERACTIONSMany herbal and dietary supplements have devel-opeddruginteractionswithprescriptiondrugs.Vita-mins, glucosamine–chondroitin, fish oil, and coen-zymeQhaveinteractedwithwarfarin.Atotalof62%of herbal supplements used have had interactionswithwarfarin.
DRUG–OVER-THE-COUNTER DRUG INTERACTIONSVarious over-the-counter (OTC) medications mayeither increase or decrease the effects of a prescrip-tion medication. For example, aspirin can increasetheeffectofwarfarin,andantacidscandecreasetheeffectsofcimetidine.
DRUG–LABORATORY INTERACTIONSMany drugs used today have demonstrated theymayhaveaneffectonserumpotassiumandcreatinelevelsinthebody.Theseinteractionscanresultinad-ditionaltestingtodetectabnormalities.
DRUG–NUTRIENT INTERACTIONSPoornutritionmayaffectthemetabolismofvariousdrugs. An example of a drug–nutrient interactionoccurswhenwarfarinandvitaminKaretakensimul-taneously.
EXAMPLES OF DRUG–FOOD INTERACTIONS• Improvedabsorptionoccursifthefollowingdrugs
aretakenwithafattymeal:ketoconazole,nitrofu-rantoin,andgriseofulvin.
• Decreased absorption occurs if the followingdrugsaretakenwithfood:tetracycline,ciprofloxa-cin, etidronate, phenytoin, norfloxacin, zidovu-dine,levothyroxine,anddidanosine.
• Grapefruit juice affects the following drugs me-tabolized by cytochrome P450: calcium channelblockers,estrogens,cyclosporine,midazolam,andtriazolam.
• Warfarin interacts with foods high in vitamin K,suchasromainelettuceandspinach.Warfarinus-ersshouldconsultacardiologistorinternistforalistofthesefoods.
DRUG-RELATED PROBLEMS
• An event or situation involving drug therapythat actually or potentially interferes with theoptimumoutcome.Thesedrug-relatedproblemsinclude an untreated indication, improper drugselection, subtherapeutic dosage, failure to re-ceiveadrug,overdosage,anddrugusewithoutanindication.
PREGNANCY CATEGORIES
When pregnancy appears as a contraindication orprecautiontotheuseofadrug,itiscategorizedasbytheFoodandDrugAdministrationinoneoffivedif-ferentcategories:• Category A: Adequate studies in pregnant
womenhavefailedtoshowarisktothefetusinthe first trimester, and there is no risk in latertrimesters.
• Category B:Animalstudieshavefailedtoshowarisktothefetus,butnoadequatestudiesinpreg-nant women or animal studies have shown anadverseeffectbuthumanstudieshavenotshownarisktothefetusinthefirsttrimesterandthereisnoevidenceofriskinlatertrimesters.
• Category C: Animal studies have shown an ad-verseeffectonthefetusandtherearenoadequatestudiesinhumans,butthebenefitsmayoutweightherisks.
• Category D: Positiveevidenceofhumanfetalrisk,butthebenefitsoutweightherisks.
• Category X: Animalorhumanstudieshaveshownfetal abnormalities or toxicity, and the risk out-weighsthebenefits.
18 Mosby’s Review for the Pharmacy Technician Certification Examination
SULFONAMIDESMechanism of action (MOA): Interfere with para-aminobenzoic acid and folic acid formation andthusdestroybacteriaCommon indications: Urinary tract infections (UTIs),otitis media, ulcerative colitis, lower respiratoryinfectionsAdverse reactions: Photosensitivity resulting in sun-burns,rashes,nauseaandvomiting,jaundice,bloodcomplications,andkidneydamageContraindications/cautions:Hepaticorrenalimpairment
Special considerations
• Avoid direct sunlight or use sunscreens whenexposed.
• Drinkplentyofwatertopreventcrystallizationintheurine.
• Sulfamethoxazole–trimethoprim infusion fluidsneedtobestoredatroomtemperature.
WORD STEM CLASSIFICATION WORD STEM CLASSIFICATION
-astine Antihistamine -prazole Antiulcer-azepam Antianxiety -pril ACEinhibitor-caine Localanesthetic -sartan AngiotensinIIreceptorantagonist-cillin Penicillin -semide Loopdiuretic-conazole Systemicantifungal -setron Serotonin(5-HT3)antagonistestr- Estrogen sulfa- Sulfonamide-glitazone Antiabetic -terol Bronchodilator-micin Aminoglycoside -tidine H2receptorantagonist-thromycin Macrolide -e-triptyline;-amine Tricyclicantidepressant-olol Beta-blocker -oxetine Fluoxetine-typeantidepressant-olone Steroid -vastatin HMGCoAreductaseinhibitor-profen Antiinflamatory
ACE,Angiotensin-convertingenzyme.
AcompletelistingofthewordstemsissuedbytheU.S.AdoptedNamesCouncilcanbefoundinAppendixB.
CONDITIONS AND TREATMENTS FOR THE IMMUNE SYSTEM
Bacterial infections: Occur when the body’s immunesystem is unable to resist bacteria. Symptoms of abacterialinfectionincludeafevergreaterthan101°Fandanincreaseinwhitebloodcells.Multidrug-resistant infections: An infection caused bybacteriathatisresistanttooneormoredrugclassifi-cations.Someexamplesofmultidrug-resistantinfec-tionsincludethefollowing:• Methicillin-resistantStaphylococcus aureus(MRSA)• Vancomycin-resistantS. aureus(VRSA)• Multidrug-resistant Streptococcus pneumoniae
(MDRSP)• Gram-negativeresistantbacilli(GNRB)• Vancomycin-resistantenterococcus(VRE)Pneumonia:An infectionthatcausesacute inflamma-tion in theairwaysof the lung,blocking themwiththickmucus
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
sulfamethoxazole–trimethoprim Bactrim,Septra Oralsuspension,tablet,IV 1tabPObidsulfadiazine Silvadene Cream Apply1–2timesadaysulfasalazine Azulfidine Tablet,enteric-coatedtablet,oralsuspension 1tabPOqid
EXAMPLES OF SULFONAMIDES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
DRUG NOMENCLATURE
Adrugmayhavethreedifferentnames:• Chemical name: Determined by chemical struc-
tureofthedrugentity• Proprietary (brand or trade) name:Assignedbythe
drugmanufacturerandisprotectedthroughapatent
• Nonproprietary (generic) name: Assigned to amedication and contains a word stem that hasbeenissuedbytheU.S.AdoptedNamesCouncilKnowledgeofprefixes,rootwords,andsuffixesal-
lowsapharmacytechniciantoidentifythedrugclassi-ficationandsubsequentlyitsindication.Someofthesedrugprefixesandsuffixesencountereddailyinclude:
Chapter 1 Pharmacology for Technicians 19
CEPHALOSPORINSMOA:PreventbacteriafromformingacellwallIndications:Dentalwork,heartandpacemakerproce-dures,orthopedicsurgery,pneumonia,upperrespi-ratoryinfections(URIs),andsinusinfectionsAdverse reactions: Diarrhea, hives, rash, wheezing,anaphylaxis
Contraindications/cautions: Hypersensitivity to penicil-lin, history of gastrointestinal (GI) problems, renalimpairmentSpecial considerations:Approximately10%ofthepop-ulationmayhaveacross-sensitivitytopenicillin.
PENICILLINSMOA:PreventbacteriafromformingacellwallCommon indications: Abscesses, meningitis, otitis me-dia,pneumonia,respiratoryinfections,prophylaxisAdverse reactions: Diarrhea, hives, rash, wheezing,anaphylaxis
Contraindications/cautions:Hypersensitivitytob-lactams,seizuredisorders,renalimpairmentSpecial considerations:Takeonanemptystomachwithwater;avoidtakingwithcolasorjuices.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
amoxicillin Amoxil,Polymox Capsule,oralsuspension,chewabletablet 1cap/tabPOtidampicillin Omnipen Capsule,oralsuspension 1capPOqidamoxicillin1clavulanate Augmentin Chewabletablet,tablet,suspension 1tabPObiddicloxacillin Dynapen Oralsuspension,oraltablet,chewabletablet 1capq6hpiperacillin None Powderforinjection 3–4gIM/IVq4–6hpiperacillin1tazobactam Zosyn Powderforinjection,solutionforinjection 3.375gIVq6hfor7–10dayspenicillin Veetids Tablet,oralsuspension 1tabPO4timesadayfor10daysticarcillin–clavulanate Timentin IV 3.1gIVq4–6h
PENICILLINS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
cefaclor Ceclor Capsule,oralsuspension,extended-releasetablet 1capPOq8hcefdinir Omnicef Capsule,oralliquid 1capPOq12hfor10dayscefixime Suprax Oralsuspension,tablet 1tabPOdailycefepime Maxipime Injection(IV) 1–2gIVq12hcefpodoxime Vantin Oralsuspension 100–400mgPObidcefadroxil Duricef Capsule,oralsuspension,tablet 1–2gPOdivq12–24hceftaroline–fosamil Teflaro IV 600mgIVq12h35–7daysceftibuten Cedax Oralsuspension,capsule 1tabPOqdceftriaxone Rocephin IM,IV 1–2gIM/IVq24hcefuroxime Ceftin,Zinacef IM,IV,oralsuspension,tablet 1tabPObid310dayscephalexin Keflex Capsule,oralsuspension,tablet 1capPOqidcefprozil Cefzil Oralliquid,capsule 1capPOq12h310days
CEPHALOSPORINS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
CARBAPENEMS AND MONOBACTAMSMOA:InhibitbacterialcellwallsynthesisIndications:Gram-positiveandgram-negativebacteriaContraindications/cautions:Hypersensitivitytomultipleallergens,seizurehistory,CNSdisordersAdverse reactions:Sameaspenicillinandcephalospo-rin,butthereisanincreasedpossibilityofseizures.
GENERIC NAMEBRAND NAME
DOSAGE FORM DOSAGE*
ertapenem Invanz Injection(IV) 1gIM/IVqd35–14days
imipenem–cilastatin
Primaxin Injection(IV) 250–500mgIVq6h
CARBAPENEM AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
20 Mosby’s Review for the Pharmacy Technician Certification Examination
TETRACYCLINESMOA:InhibitproteinsynthesisinbacteriabybindingribosomesIndications: Acne, chronic bronchitis, Lyme disease,RockyMountain spotted fever, “walking”pneumo-nia,prophylaxisfortraveler’sdiarrheaAdverse reactions: GI, such as nausea and vomiting;photosensitivity tosunlight, resulting inrashesandsunburns
Contraindications/cautions: Pregnancy, renal or hepaticimpairment
Special Considerations
• May bind to antacids and dairy productsand therefore decrease the effectiveness of theantibiotic
• Tetracyclinesshouldbetakenseveralhoursapartfrom antacids and dairy products because of thepossibilityofchelation.
• They should not be taken by pregnant womenbecauseofthepossibilityofdentalbirthdefects.
• Childrenyoungerthan9yearsshouldnotbegiventetracyclines.
• Takingexpiredtetracyclinemayresult in toxicityandpossiblydeath.
• Doxycyclineshouldbeprotectedfromlight.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
doxycyclinehyclate Vibramycin Capsule,IV,oralsuspension,tablet 100mgPOqddoxycyclinemonohydrate Monodox Tablet 100mgPOqdminocycline Minocin Capsule,IV,oralsuspension,tablet 100mgPOq12htetracycline Sumycin Capsule,oralsuspension,topical 1–2g/dayPOdivbid–qid
TETRACYCLINES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
MACROLIDESMOA: Inhibit protein synthesis by interacting withribosomesIndications: Pulmonary infections, chlamydia, Hae-mophilus influenzaeAdverse reaction:MaycauseGIdistressContraindications/cautions: Hepatic or renal impair-ment,QTprolongation
Special Considerations
• Thepatientshouldtakemacrolideswithfood.• Clarithromycinmayleaveametallictasteinone’s
mouth.• Thefirstdoseofazithromycinisaloadingdose.
GENERIC NAME
BRAND NAME
DOSAGE FORM DOSAGE*
aztreonam Azactam IV 1–2gIM/IVq8–12h
MONOBACTAM AGENT
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
azithromycin Zithromax Capsule,oralsuspension 500mgPO31onday1;then250mg/day34days
clarithromycin Biaxin Granulesfororalsuspension,film-coatedtablet
250–500mgPOq12h37–14days
erythromycinbase Eryc,E-Mycin,Ery-Tab
Capsule,tablet,enteric-coatedtablet,film-coatedtablet
1000mg/dayPOdivq6–12h
erythromycinethylsuccinate E.E.S. Oralsuspension,tablet,chewabletablet 1600mg/dayPOdivq6–12herythromycinstearate Erythrocin Film-coatedtablet,IM,IV 1000mg/dayPOdivq6–12herythromycin–sulfisoxazole Pediazole Oralsuspension 40–50mg/kg/dayPOdivq6–8herythromycinlactobionate Erythrocin IV 15–50mg/kg/dayIVdivq6h
MACROLIDES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Chapter 1 Pharmacology for Technicians 21
KETOLIDESMOA:Blockproteinsynthesisbybindingtoribosomalsubunits;mayinhibittheformationofnewlyformingribosomesIndications: Used to treat bacterial infections in thelungsandsinusesAdverse reactions:Blurredvision;sideeffectssimilartothoseofmacrolidesContraindications/cautions: Myasthenia gravis, hyper-sensitivity to macrolides, hepatic impairment, QTprolongation
QUINOLONESMOA:AntagonizeanenzymerequiredforDNAsyn-thesis,causingDNAbreakageandfinallydeathIndications: Bone and joint infections, dental work,infectiousdiarrhea,URIs,andUTIsAdverse reactions: Nausea and vomiting, joint swell-ing,dizzinessContraindications/cautions: Myasthenia gravis, patientsyoungerthan18yearsofage,andpatientsolderthan60yearsofage
Special Considerations
• Antacidsinterferewithabsorption.• Potentiatestheeffectoftheophyllineproductsand
maycausetoxicity• Causephototoxicity• Shouldnotbegiventopregnantwomen• Ciprofloxacin injection should be protected
fromlight.• Ofloxacin injection needs to be protected
fromlight.
GENERIC NAMEBRAND NAME
DOSAGE FORM
DAILY DOSAGE*
telithromycin Ketek Tablet 800mgPOqd37–10days
KETOLIDE AGENT
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
ciprofloxacin Cipro Tablet,oralsuspension,ophthalmic,IM,IV 250–750mgPOq12hlevofloxacin Levaquin IV,tablet 500mgPO/IVq24h37daysmoxifloxacin Avelox,Vigamox Tablet,IV(Vigamox—ophthalmicuseonly) 400mgPO/IVq24h35–14daysnorfloxacin Noroxin Tablet 400mgPObidofloxacin Floxin,Ocuflox Tablet,ophthalmic 200–400mgPOq12h
QUINOLONE AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
STREPTOGRAMINSMOA:InhibitbacterialproteinsynthesisIndications: Gram-positive infections, Enterococcus faecium, and vancomycin- and methicillin-resistantinfectionsAdverse reactions: Nausea, vomiting, joint swelling,dizziness.Thereisapossibilityofanadversereactionoccurringatthesiteofinfusion.
Contraindication/caution: Hypersensitivity to drug,class,orcomponent
Special Considerations
• Synercidshouldnotcomeintocontactwithsalineor other medications. It must be stored in therefrigerator.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
Quinupristin–dalfopristin Synercid IV 7.5mg/kgIVq8h
STREPTOGRAMIN AGENT
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
22 Mosby’s Review for the Pharmacy Technician Certification Examination
AMINOGLYCOSIDESMOA:InhibitbacterialproteinsynthesisIndications:Life-threatening infections,sepsis, immu-nocompromisedpatientsAdverse reactions:Nephrotoxicity,ototoxicity,tinnitus,permanentdeafnessContraindications/cautions: Neuromuscular blockade,nephrotoxicity,neurotoxicity
Special Considerations
• Doses need to be adjusted for each patient afterthefirstdoseandcloselymonitored,especiallyinpatientswithrenalimpairment.
• Once-per-day dosage has the tendency toreduce toxicity; however, monitoring is stillrequired.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
gentamicin Garamycin Cream,IM,IV,ophthalmic 1–1.7mg/kgIM/IVq8hstreptomycin Streptomycin IM 1–2g/dayIMq6–12htobramycin Nebcin IV,ophthalmic,inhaler 1–1.7mg/kgIM/IVq8h
AMINOGLYCOSIDE AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
CYCLIC LIPOPEPTIDESMOA:Bindtobacterialmembranesandcausethecellmembranetodepolarize,resultinginaninhibitionofDNAandRNAsynthesisIndications:Used to treat complicated skin infectionsandaerobicgram-positivebacterialinfectionsAdverse reactions: Hypotension, headache, insomnia,allergicsitereactionsContraindication/caution:ElderlypatientsSpecial consideration: Should not be taken with3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)reductaseinhibitors
CYCLIC LIPOPEPTIDE
GENERIC NAMEBRAND NAME
DOSAGE FORM DOSAGE*
daptomycin Cubicin IV 4mg/kgIVq24h37–14days
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
MISCELLANEOUS ANTIBIOTICS
Clindamycin (Cleocin)MOA:InhibitsproteinsynthesisIndications: Acne, dental prophylaxis for penicillin-allergicpatients,infectionscausedbyanaerobicorgan-isms,boneinfections,femalegenitalinfectionsAdverse reaction: BloodydiarrheaContraindications/cautions: Clostridium difficile–associateddiarrhea,ulcerativecolitis,hepaticorrenalimpairmentSpecial consideration: Should be avoided duringpregnancy
Metronidazole (Flagyl)
MOA:Destroyspartsofthebacteria’sDNAnucleusIndications: Trichomonas infections of vaginal canal,cervix, andmaleurethra; amebicdysentery; intesti-nalinfectionsAdverse reactions: Metallic taste, diarrhea, rash, and“Antabuse-likereaction”whenalcoholisconsumed.AnAntabuse-like reaction results in blurred vision,confusion,difficultbreathing,hotandscarletface,anintense throbbing in the head and neck, and chestpains.Contraindications/cautions:Pregnancy,blooddyscrasiasSpecial consideration: Take with food, and avoid anyformofalcohol1daybefore,during,and2daysaftertherapywithmetronidazole.
Pentamidine (NebuPent, Pentam)
MOA:UnknownIndication:IndicatedforthetreatmentofPneumocystis cariniiinfectionAdverse reactions:Hypotension,wheezing,coughingContraindications/cautions:Hypertension,tachycardiaSpecial consideration: If themedication is inhaled, thedosemustbedilutedwithsterilewateranddeliveredatarateof6mL/minbyanebulizer.
Linezolid (Zyvox)
MOA:InhibitsbacterialproteinsynthesisIndications:Usedtotreatmethicillin-resistantS. aureusandvancomycin-resistantE. faeciumandothergram-positiveinfectionsContraindications/cautions: Thrombocytopenia, uncon-trolledhypertension
Chapter 1 Pharmacology for Technicians 23
Special Considerations
• Theintravenous(IV)formmustbeprotectedfromlightandcannotbeadministeredwithothermed-ications.
• Avoidfoodsthatarehighintyramine.
Vancomycin (Vancocin)
MOA: InterfereswithbacterialwallformationIndications: Dialysis patients, endocarditis, staphylo-coccusinfectionsAdverse reactions: Red man syndrome, ototoxicity,nephrotoxicity,neutropeniaContraindications/cautions: Renal impairment, inflam-matoryboweldiseaseSpecial considerations:Bloodureanitrogenorcreatineifrenalimpairment• Potential for overuse prompted the Centers for
Disease Control and Prevention to issue specificguidelinesforuse
• Patientneedstobekepthydrated.
ANTIFUNGALSFungal infections: Caused by single-cell organismsthatdonothavechlorophyll,possessacellwall,and
reproducebyspores.Fungusdevelopsinindividualswhoseimmunesystemshavebeencompromisedbydisease,drugtherapy,orpoornutrition.Tinea infections:AfungalinfectionoftheskinorfeetMOA:Preventsynthesisofergosterolandinhibitfun-galcytochromeP450Adverse reactions:Livertoxicitiesmaydevelop;there-fore, liver function tests are recommended. GI dis-tressmayoccur.Photosensitivity,rashes,andnauseaareothercommonsideeffects.
Special Considerations
• Antifungalsmaybeusedaseithertopicalorsys-temicagents.
• Pulse dosing is recommended for nail fungalinfections.
• Consuming a cola before taking itraconazole isrecommended.
• Fattymealsshouldbetakenwithgriseofulvin.• Fluconazole suspension should be refrigerated
andexpiresin14days.
GENERIC NAME BRAND NAME(S) DOSAGE FORMS DAILY DOSAGE* RX or OTC
amphotericinB Amphotec,Fungizone,Amphocin
IV,topical 3–4mg/kg/dayIV
butenafine Mentax Topicalcream Apply1–2timesadayfor7–14days
RXandOTC
ciclopirox Loprox Topical Applytwiceadayfor1–4weeksclotrimazole Lotrimin Oraltroche,topical,vaginal 10mgPO53day314days RX:troche
OTC:creamclotrimazole–
betamethasoneLotrisone Cream Applybid
fluconazole Diflucan IV,tablet,oralsuspension 100mgPO/IVqdgriseofulvin Grisactin,Fulvicin,
Gris-PEGCapsule,tablet,oral
suspension500mgPOqd32–4wk
itraconazole Sporanox Capsule,oralsuspension 200mgPObid37days;off21days
ketoconazole Nizoral Tablet,topicalcream,shampoo
200–400mgPOqd
miconazole Monistat Topical,vaginal Variesbecauseofdosageandcondition
OTC
nystatin Nilstat Tablet,oralsuspension,topical,vaginal
4–6mLPOqd;1–2tabsPOtid
oxiconazole Oxistat Cream,lotion Apply1–2timesadayfor14days
sertaconazole Ertaczo Cream Applytwiceadayfor4wksulconazole Exelderm Cream Apply1–2timesadayterbinafine Lamisil Tablet,topicalcream,
solution1tabPOqd36–12wk
terconazole Terazol Vaginalcream,suppository 1applicator(supp)vaghs33–7days(dependingondosage)
voriconazole Vfend IV,oralliquid,tablet 1tabPO1hacorpc;3mg/kg/hinfusedover1–2h(IV)
ANTIFUNGAL AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
24 Mosby’s Review for the Pharmacy Technician Certification Examination
ANTIVIRALSViral infections: Causedbyagentssmallerthanbac-
teria,whicharenormallyspreadbydirectcontact,ingestion of contaminated food and water, orinhalation of airborne particles. Viral infectionsmaybeacute,chronic,orslowinnature,andtheinfectionmaybelocalorgeneralized.Theirsymp-tomsaremoreseverethaninbacterial infectionsand include malaise, myalgia, headaches, chills,orfever.
Herpes: Anoutbreakoftheskinthatcausespainfulblister-likeeruptionsandiscausedbyavirus
Influenza: Arespiratorytractinfectioncausedbyaninfluenzavirus
MOA: InhibitpenetrationofthehostcellIndications: Cytomegalovirus retinitis, genital herpes,herpessimplex,herpessimplexkeratitis,herpeszoster(shingles), influenza prophylaxis, organ transplants,varicella,chickenpoxAdverse reactions: Headaches,nausea,vomiting,diar-rhea,constipation,renaldisordersContraindications/cautions: Renal or hepatic impair-ment,electrolyteimpairments
Special Considerations
• Oralproductsshouldbetakenwithplentyofwater.• Whenacyclovirisreconstituted,theinjectionsolu-
tionshouldbeusedwithin12hours.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
acyclovir Zovirax Capsule,tablet,oralsuspension,IV,ointment
200–800mgq4h5timesdailyfor7–10days
amantadine Symmetrel Capsule,syrup 200mgPOqdcidofovir Vistide IV 5mg/kgIVover1hfamciclovir Famvir Tablet 200–1000mgPOqdfoscarnet Foscavir IV 90mg/kg(over1–1½h)q12hganciclovir Cytovene Capsule,IV 5mg/kgover1hq12hfor14–21daysoseltamivir Tamiflu Capsule,oralliquid 75mgbid35dayspenciclovir Denavir Cream Applyq2hduringwakinghours34daysrimantadine Flumadine Tablet 100mgbid37daysribavirin Virazole Aerosolinhalant Continuousaerosoladministrationfor12–18hfor
3–7daysvalacyclovir Valtrex Caplet Dosagevariesbyconditionbeingtreatedvalganciclovir Valcyte Tablet,oral 900mgbid321dayszanamivir Relenza Inhalant 10mgbid35days
ANTIVIRAL AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
ANTIRETROVIRALSHuman immunodeficiency virus (HIV): A blood-
borne sexually transmitted viral disease thatcauses the host to become too weak to fight anyinfection
Acquired immunodeficiency syndrome (AIDS): Anend-stage disease that occurs as a result of HIVwhen the CD4 T-cell count is less than 200 permicroliterofblood
Indication:LimitstheprogressionoftheretrovirusthatcausesHIV,whichmayprogresstoAIDS
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Indication: AssistinthetreatmentofHIVdiseaseMOA:Inhibitthereleaseofneuraminidase,aviralen-zyme, toprevent the spreadof thevirus tohealthycells.NRTIsbindandinhibittheactionofneuramin-idase. This results in the formation of a defectiveproviralnucleus,whichisunabletobecomepartofthehostcell’snuclei.Contraindications/cautions: Pancreatitis,lacticacidosisAdverse reactions: Nausea, vomiting, peripheralneuropathySpecial consideration: Shouldnotbeusedduringlactation
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
abacavir(ABC)† Ziagen Solution,tablet 300mgPObidor600mgPOqddidanosine(ddI)† Videx,VidexEC Capsule,tablet,powder 200mgPObidemtricitabine(FTC)† Emtriva Tablet 200mgPOqdlamivudine(3TC)† Epivir Tablet,solution 150mgPOqdor300mgPOqdstavudine(d4T)† Zerit Capsule,powder 30–40mgPOqd
NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs)
Chapter 1 Pharmacology for Technicians 25
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Indications: AidinthetreatmentofHIVdiseaseMOA: Inhibittheactionofneuraminidasebyprevent-ingtheformationoftheproviralDNAAdverse reactions: Dizziness,headache, rashes,night-mares,hallucinations,hepatotoxicityContraindication/caution: Hepaticimpairment
Special Considerations
• Druginteractionsarecommon.• Can induce or inhibit the cytochrome P450
systems• Resistance to one NNRTI results in resistance to
theothers.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
tenofovir(TDF)† Viread Tablet 300mgPOqdzalcitabine(ddC)† Hivid Tablet 0.75mgPOq8hzidovudine(AZT)† Retrovir Capsule,syrup,IV 600mgPOqdindivdosesabacavir-lamivudine Epzicom Tablet 1tabPOqdemtricitabine–tenofovir Truvada Tablet 1tabPOqdzidovudine–lamivudine(CBV)† Combivir Tablet 1tabPObidzidovudine–lamivudine–
abacavir(TRZ)†Trizivir Tablet ItabPObid
NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs)—cont’d
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†BothTheJointCommissionandtheInstituteforSafeMedicationPracticesareagainsttheusingofabbreviationsformedications;however,physiciansmaystillusetheseabbreviations.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
delavirdine(DLV)† Rescriptor Capsule,tablet 1–2tabPOtidetravirine Intelence Tablet 200mgPObidefavirenz(EFZ)† Sustiva Capsule 600mgPOqdnevirapine(NVP)† Viramune Capsule,tablet 1tabPOqd314days,then1tabPObid
NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIs)
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†BothTheJointCommissionandtheInstituteforSafeMedicationPracticesareagainsttheusingofabbreviationsformedications;however,physiciansmaystillusetheseabbreviations.
Protease Inhibitors
Indication: AssistinthetreatmentofHIVMOA: PreventthecleavageofcertainHIVproteinpre-cursors, which are necessary for the replication ofnewviruses
Adverse reactions: Redistribution of body fat (“prote-ase paunch,” humped back), facial atrophy, breastenlargement,hyperglycemia,hyperlipidemiaContraindications/cautions: Nephrolithiasishistory,dia-betes,hepaticimpairment
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
amprenavir Agenerase‡ Capsule,oralliquid 1200mgPObidatazanavir Reyataz Capsule 300–400mgPOqdfosamprenavir(FPV)† Lexiva Tablet 700–1400mgPOqd–bidindinavir(IDV)† Crixivan Capsule 2capsPOq8hlopinavir–ritonavir(LPV/r)† Kaletra Solution,capsule 3–6capsPOqd–bidnelfinavir(NFV)† Viracept Powder,tablet 750mgPOtidor1250mgPObidritonavir(RTV)† Norvir Solution,capsule 600mgPObidsaquinavir(SQV-SGC)† Invirase Capsule 1000mgPObidtipranavir Aptivus Capsule 500mgPObid
PROTEASE INHIBITORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†BothTheJointCommissionandtheInstituteforSafeMedicationPracticesareagainsttheusingofabbreviationsformedications;however,physiciansmaystillusetheseabbreviations.‡BrandisnolongeravailableintheUnitedStates.
26 Mosby’s Review for the Pharmacy Technician Certification Examination
Fusion Inhibitor
Indication: AidsinthetreatmentofHIVMOA: Prevents AIDS virus from entering immunecellsAdverse reactions: Skin reactions, which may causebruising,cysts,itching,bumps,pain,andredness
Contraindication/caution: Pulmonarydisease
Special Considerations
• TheproducthasapregnancycategoryBrating.• Itisdilutedwithsterilewater.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
enfuvirtide Fuzeon SCinjection 90mgSCbidmaraviroc Selzentry Tablet 300mgPObid
FUSION INHIBITORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
ANTIPROTOZOAL AGENTSIndications: Malaria,extraintestinalamebiasisMOA: Unknown
Adverse reactions: Nauseaorvomiting,anorexia,diar-rhea,abdominalpainContraindications/cautions: Retinal field changes, long-termusage
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
chloroquine Aralen Tablet 500mgpoqwkiodoquinol Yodoxin Tablet 650mgpotid320daysmefloquine † Tablet 250mgpoqwkmetronidazole Flagyl Tablet 750mgpotid35–10dayspraziquantel Biltricide Tablet 54–25mg/kgpo31doseprimaquine Primaquine Tablet 30mgpoqd314dayspyrimethamine Daraprim Tablet 25mgpoqwk310wk
ANTIPROTOZOAL AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
ANTIHISTAMINES, ANTITUSSIVES, DECONGESTANTS, AND EXPECTORANTSAllergies:Aresponseofourimmunesystemdueto
anunrecognizedsubstanceRhinitis: An irritation and inflammation of the
mucousmembranesliningthenasalpassages
Antihistamines
Indications: Treatment of allergies, insomnia, rashes,hay fever, dizziness; prophylaxis for drug reactionsandallergies
MOA: Blockthereleaseofhistamine(H1)intherespi-ratorysystemAdverse reactions: Drowsiness, anticholinergic reac-tions such as drying up of body fluids, possiblehyperactivityinchildrenContraindication/caution: Renalimpairment
Special Considerations
• Antihistamines have a synergistic effect withalcohol.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
azelastine Astelin Spray 1–2sprayspernostrilbidbudesonide RhinocortAqua Nasalspray 1–4sprays/nostrilqdcetirizine Zyrtec Tablet 5–10mgPOqd OTCchlorpheniramine Chlor-Trimeton Tablet,capsule 1tabPOq4–6hprn OTCciclesonide Omnaris Nasalspray 2sprayspernostrilqdclemastine Tavist Tablet 1tabPOq12hprn OTCcyproheptadine † Tablet,syrup 1tabPOtiddexamethasone Decadron Tablet,elixir Dosingvariesbyconditiondiphenhydramine Benadryl Capsule,tablet,topical,elixir,strips 1–2tabs/caps/stripsPOq4–6h RXandOTC
ANTIHISTAMINES
Chapter 1 Pharmacology for Technicians 27
AntitussivesIndication: TreatmentofcoughMOA: DepressionofthecoughcenterorsuppressionofnervereceptorsinrespiratorysystemAdverse reactions: CNSdepression,nausea,lightheaded-nessContraindication/caution: CNSdepression
Special Considerations
• Dextromethorphaninteractswithmonoamineoxi-daseinhibitors(MAOIs).
• Benzonatateshouldbeswallowedbutnotchewed.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
fexofenadine Allegra Tablet 1tabPObid OTCfluticasone Flonase Nasalspray 2spraypernostrilperdayhydroxyzineHCl † Tablet,capsule,syrup,IM,IV 1tabPOtid–qidhydroxyzinepamoate Vistaril Capsule,syrup 1capPOtid–qidloratadine Claritin Tablet,syrup 1tabPOqd OTCmeclizine Antivert,Bonine Tablet,capsule,chewabletablet 1tabPOtid–qid OTCmometasone Nasonex Nasalspray 2sprayspernostrilqdolopatadine Patanol Ophthalmicsolution 1gttineyebidpromethazine † Tablet,syrup,suppository,IM,IV 25mgbidtriamcinolone NasacortAQ Nasalspray 1–2spraysqnostrilqd
ANTIHISTAMINES—cont’d
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
benzonatate TessalonPerles Capsule 1capPOtidprncoughcodeine Codeine Tablet,elixir 15–60mgPOq4hdextromethorphan Benylin,Delsym,Hold,
RobitussinDMSyrup,lozenges 10mLPOq12hprn OTC
hydrocodone–homatropine † Syrup,tablet 1tabor1tspPOq4–6hpromethazine–codeine † Oralliquid 1tspPOq4–6hpromethazine–
dextromethorphan
† Oralliquid 1tspPOq4–6h
ANTITUSSIVES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Decongestants
Indications: Temporaryreliefofnasalcongestionfromthe common cold, sinusitis, and upper respiratoryallergiesMOA: Stimulation of the a-adrenergic receptors, re-sulting in constriction of the dilated arteries withinthenasalmucosaAdverse reactions: CNS stimulation, increased bloodpressure, increased heart rate, insomnia, anxiety,tremor,rhinitismedicamentosa,andheadache
Contraindications/cautions: Urinary retention, coronaryarterydisease,uncontrolledhypertension
Special Considerations
• Decongestants should be avoided if the patienthas diabetes, heart disease, hypertension, hyper-thyroidism, prostatic hypertrophy, or Tourettesyndrome.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
oxymetazoline Afrin Nasaldrops,spray/mist 2–3spraysqnostrilq10–12hprn OTCphenylephrine Neo-Synephrine,
Neo-SynephrineIINasaldropsandspray 2–3spraysqnostrilprn OTC
pseudoephedrine Sudafed Capsule,tablet,oralsolution 1tabPOq6h OTCsoldbehindthecounter
DECONGESTANTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
28 Mosby’s Review for the Pharmacy Technician Certification Examination
Expectorants
Indications: To remove mucus from both lungs andairwaypassagesduringcoughingMOA: DecreasethicknessofmucusbydecreasingtheviscosityoftheliquidAdverse reactions: Nausea and vomiting, drowsiness,GIdistress
Contraindications/cautions: Nephrolithiasis, patientsyoungerthan6yearsofageSpecial consideration: Patientshouldconsumeplentyofwaterwhiletakingmedication.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
guaifenesin Mucinex Capsule,caplet,liquid,tablet 1tspPOq4–6h OTC
EXPECTORANT
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE* RX OR OTC
chlorpheniramine/hydrocodone TussionexPennKinetic Suspension 5mLq12hguaifenesin–codeine RobitussinA-C Liquid 1tspPOq4–6hprncough Exemptnarcoticguaifenesin–pseudoephedrine MucinexD Tablet 2tabPOq12h OTCpromethazine–codeine Phenergan/codeine Syrup 5mLPOq4–6h
COMBINATION EXPECTORANTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE* RX OR OTC
cetirizine–pseudoephedrine Zyrtec-D Tablet 1tabPOq12h OTC(behindthecounter)fexofenadine–pseudoephedrine Allegra-D Tablet 1tabPOq12h OTC(behindthecounter)loratadine–pseudoephedrine Claritin-D Tablet 1tabPOq12h OTC(behindthecounter)
COMBINATION DECONGESTANTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Chapter 1 Pharmacology for Technicians 29
CONDITIONS AND TREATMENTS FOR THE NERVOUS SYSTEM
Anxiety: A state of uneasiness characterized byapprehension and worry about possible eventsresulting from either exogenous or endogenousstress
Panic disorders: Intense anxiety characterized by asense of fear, apprehension, or a premonition ofseriousillnessoralife-threateningattack
MOA for Antianxiety Agents
Adverse reactions: May cause either physical or psy-chological dependence, drug accumulation, birth
defectsiftakenduringearlypregnancy,musclerelax-ation,sedation,anddepressionContraindications/cautions:Pulmonaryimpairment,sleepapnea,CNSdepression,seizurehistory
Special Considerations
• Many agents used to treat anxiety are controlledsubstances;therefore,federalandstatecontrolledsubstancelawsmustbeobeyed.
• Shouldbetaperedondiscontinuation
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* CONTROLLED SUBSTANCE
alprazolam Xanax Tablet 0.25–0.5mgPOtid Yesamoxapine † Tablet 100mgPObid–tid Nobuspirone BuSpar Tablet 20–30mgPOqd Nochlordiazepoxide Librium Capsule,injection 5–10mgPOtid–qid Yesclorazepate Tranxene Capsule,tablet 15–60mgPOqdindivideddoses Yesdiazepam Valium Tablet,injection 2-10mgPObid–qid Yeslorazepam Ativan Tablet,IM,IV 2–3mgPOqdindivideddoses Yesmeprobamate † Tablet 1200–1500mgPOindivideddoses Yesoxazepam Serax Capsule,tablet 10–15mgPOtid–qid Yes
ANTIANXIETY AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Depression:Psychiatricdisorderthatmaybecausedbychanges inneurotransmitters (e.g.,dopamine,norepinephrine,orserotonin)inthebrain;symp-tomsincludealossofinterestinnormalactivities,lowself-esteem,pessimism, self-pity,weight lossorgain,insomnia,lossofenergy,feelingsofworth-lessness,feelingsofguilt,orrecurrentthoughtsofdeathorsuicide
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)Indications: Major depression, obsessive-compulsivebehavior,anxiety
MOA:BlockthereuptakeofserotoninAdverse reactions:Nervousness,insomnia,nausea,di-arrhea, loss of weight, decreased libido, ejaculatorydisturbancesContraindications/cautions: Pregnancy, elderly patients,hepaticimpairment
Special Considerations
• DelayofonsetforSSRIsis10to21days.• Alcoholshouldbeavoided.• Thesedrugsinteractwithphenytoin.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
citalopram Celexa Tablet,liquid 20–40mgPOqamescitalopram Lexapro Tablet 10mgPOqamfluoxetine Prozac Capsule,liquid 20–80mgPOqamfluvoxamine Luvox Tablet 50mgPOqhsparoxetine Paxil Tablet 20–50mgPOqamsertraline Zoloft Tablet 50mgPOqam
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
30 Mosby’s Review for the Pharmacy Technician Certification Examination
SELECTIVE SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSNRIs)MOA:InhibitnorepinephrineandserotoninreuptakeIndications:Majordepressivedisorder,diabeticneuro-pathicpain,generalizedanxietydisorder
Adverse effects: Suicidality, hypomania, withdrawalsyndromeContraindications/cautions:Hepaticimpairmentordisease
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
desvenlafaxine Pristiq Tablet 50mgPOqdduloxetine Cymbalta Capsule 40–60mgPOqamvenlafaxine Effexor Timed-releasecapsule 75–150mgPOwithfood
SELECTIVE SEROTONIN AND NOREPINEPHRINE INHIBITORS (SSNRIs)
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
TRICYCLIC ANTIDEPRESSANTS (TCAs)Indications:Depression,nocturia(bedwetting)inchildrenMOA:BlockreuptakeofnorepinephrineorserotoninAdverse reactions:Cardiotoxic inhighdoses,posturalhypotension in elderly adults, drowsiness, anticho-linergiceffects
Contraindications/cautions:Myocardialinfarction,elderlypatientsSpecial consideration:Noticeableresultsmaynotoccurforseveralweeks.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
amitriptyline † Tablet,injection 75–150mgPOqdindivideddosesclomipramine Anafranil Capsule 25–100mgPOqhsdesipramine Norpramin Tablet 100–200mgPOqddoxepin Sinequan,Zonalon Capsule,oralliquid,cream 75–150mgPOqdimipramine Tofranil Capsule,tablet,injection 75–150mgPOqdnortriptyline Pamelor,Aventyl Capsule,oralsolution 25mgPOtid–qidprotriptyline Vivactil Tablet 15–40mgPOqdindivideddoses
TRICYCLIC ANTIDEPRESSANTS (TCAs)
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
MONOAMINE OXIDASE INHIBITORS (MAOIs)Indication:AtypicaldepressionMOA: Inhibit enzymes that break down catechol-aminesAdverse reaction:PossiblehypertensionContraindications/cautions: General anesthesia within10days,electivesurgerywithin10days,congestiveheartfailure
Special Considerations
• Ifphysicianchangestherapy,MAOIsshouldbedis-continuedfor2weeksbeforenewtherapybegins.
• Patients should avoid certain foods containingtyramine(agedcheeses,certainwines,andcertainyeastproducts).
• MAOIs should not be taken if the patient istaking ephedrine, amphetamine, methylpheni-date,levodopa,ormeperidine.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
phenelzine Nardil Tablet,patch 15mgPOtidselegiline Eldepryl Tablet,patch 5mgPOwithbreakfastandlunchtranylcypromine Parnate Tablet,patch 30mgPOqdindivideddoses
MONOAMINE OXIDASE INHIBITORS (MAOIs)
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Chapter 1 Pharmacology for Technicians 31
BIPOLAR AGENTSBipolar disease: Depressive psychosis, alternating
between excessive phases of mania and depres-sion. Mania may be characterized by exhibitingthreeof the followingsymptoms: increasedneedforsleep,distractibility,elevatedorirritablemood,excessive involvement in pleasurable activitieswithapotentialforpainfulconsequences,grandi-ose ideas, increase in activity, pressure to keeptalking,andracingthoughts.
MOA:UnknownAdverse reactions: Bloating and abdominal distress,bloody stools, acne, leucocytosis, hand tremor, in-creasedbodyweight,polyuria,polydipsia,nocturia,abnormaldevelopmentoffetusduringpregnancy
Contraindications/cautions: MAOI use within 10 days,bonemarrowdepression
Special Considerations
• Blood levels must be established for patientstakinglithiumandshouldbeintherangeof0.6to0.8mg/mL.
• Salt content must be monitored and alcoholavoided.
• Carbamazepineinteractswithbenzodiazepines,ci-metidine, corticosteroids, cyclosporine, diltiazem,doxycycline, erythromycin, ethosuximide, isonia-zid, MAOIs, oral contraceptives, phenytoin, pro-poxyphene, theophylline, thyroid medications,TCAs,valproicacid,verapamil,andwarfarin.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
carbamazepine Tegretol Tablet,chewabletablet,suspension
200mgPOtid–qid
divalproex Depakote,DepakoteER Tablet 2540–500mgPOtidlamotrigine Lamictal,LamictalER Tablet 200mgPOqdlithium Lithobid Capsule,tablet 900–1200mg/dayPOdivbid/tidolanzapine–fluoxetine Symbyax Capsule 1capPOqamvalproicacid Depakene Capsule,syrup,IV 250–500mgPOtid
EXAMPLES OF BIPOLAR AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
ANTIPSYCHOTIC AGENTSNeurosis: A mental disorder arising from stress or
anxietyinthepatient’senvironmentwithoutlossofcontactwithreality
Phobias: A continuous irrational fear of a thing,place, or situation that causes significantdistress
Psychosis:A chronic psychotic disorder manifestedbyaretreatfromreality,delusions,hallucinations,ambivalence, withdrawal, and bizarre or regres-sivebehavior
Schizophrenia: Chronic psychotic disorder charac-terizedbyaretreatfromreality,delusions,halluci-nations, ambivalence, withdrawal, or regressivebehavior
MOA: BlockDopamine(D2)receptorsinthedopaminepathwaysofthebrain
Adverse reactions:Sedation,anticholinergicresponses,posturalhypotension,excessivetanning,hyperglyce-mia, lack of menses, nonreversible bone marrowdepression, dystonia, akathisia, and pseudoparkin-sonism.Thefollowingdrugsmayminimizethesideeffects: dimenhydrinate, benztropine, diphenhydr-amine,andtrihexyphenidyl.Contraindication/caution:Cardiovasculardisease
Special Considerations
• Gainsinreducingsymptomsmaytakeanywherefrom6to12weeks.
• Discontinuingmedicationmay lead to relapseofsymptoms.
• Thioridazinehasaceilingdoseof800mg/day.• Promazinedosageshouldnotexceed1000mg/day.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
aripiprazole Abilify Tablet 10–15mgPOqdclozapine Clozaril Tablet 150–300mgPObidfluphenazine † Tablet,liquid,IM,IV 2.5–10mg/dayPOdivq6–8hhaloperidol † Tablet,liquid,IM 0.5–5mgbid–tidiloperidone Fanapt Tablet 6–12mgPObidloxapine Loxitane Capsule,liquid,IM 30–50mgPObidlurasidone Latuda Tablet 40–80mgPOqd
ANTIPSYCHOTIC AGENTS
Continued
32 Mosby’s Review for the Pharmacy Technician Certification Examination
ANTIINSOMNIA AGENTSInsomnia: Characterized by the inability to sleep or
remainasleep,whichmaybecausedbysituations,medications,orpsychiatricormedicalconditions
MOA: Interact with g-aminobutyric acid (GABA)–benzodiazepinereceptorcomplexes
Adverse reactions: CNS depression, dizziness, confu-sion,impairedreflexesContraindications/cautions: Alcohol use, CNS depres-santuseSpecial consideration:Potentialforabuse
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
olanzapine Zyprexa Tablet 10mgPOqdprochlorperazine † Tablet,capsule,liquid,suppository,IM,IV 5mgPOq6–8hquetiapine Seroquel,SeroquelER Tablet 150–750mg/dayPOdivbid–tidpaliperidone Invega Extended-releasetablet 6mgPOqamrisperidone Risperdal Tablet,liquid 1–4mg/dayPOdivqd–bidthioridazine † Tablet,liquid 200–800mg/dayPOdivbid–qidthiothixene Navane Capsule,IM 2–5mgPObid–tidtrifluoperazine † Tablet,liquid,IM 2–5mgPObidziprasidone Geodon Capsule,injection 20mgPObid
ANTIPSYCHOTIC AGENTS—cont’d
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* CONTROLLED SUBSTANCE
chlordiazepoxide † Capsule 5–10mgPOqhs Yesdiazepam Valium Injection,IV,oralliquid,tablet 2.5–10mgPOqhs Yeseszopiclone Lunesta Tablet 2–3mgPOqhs Yesflurazepam Dalmane Capsule 15–30mgPOqhs Yeslorazepam Ativan Injection,IV,oralliquid,tablet 2–4mgPOqhs Yesramelteon Rozerem Tablet 8mgPOqhs Notemazepam Restoril Capsule 7.5–30mgPOqhs Yeszaleplon Sonata Capsule 5–10mgPOqhs Yeszolpidem Ambien,AmbienCR Tablet 5–12.5mgPOqhs Yes
ANTIINSOMNIA AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
ATTENTION-DEFICIT DISORDER (ADD) AND ATTENTION–DEFICIT HYPERACTIVITY DISORDER (ADHD) AGENTSADD: Aphysiologicaldisorderfoundinchildrenshow-
ingsignsofattentiondeficitwithouthyperactivityADHD: A physiological disorder in which the pa-
tienthasdifficultyfocusinghisorherattentioninaquietinattentivemannerordisplayshyperactiv-ityoracombinationofbothofthese
MOA:StimulateCNSactivity;blockreuptakeandin-crease release of norepinephrine and dopamine inextraneuronalspaceAdverse reactions: Withdrawal if abrupt discontinua-tion,depression,psychosisContraindications/cautions: Breastfeeding, cardiovascu-lardisease,glaucomaSpecial consideration:Potentialforabuseanddependency
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE* CONTROLLED SUBSTANCE
amphetamine/dextroamphetamine Adderall Tablet 5–40mgPOdivqd-tid Yesatomoxetine Strattera Capsule 80mgPOqam Nodexmethylphenidate Focalin Tablet 2.5–10mgPObid Yesdextroamphetamine Dexedrine Capsule 5–40mgPOqam Yeslisdexamfetamine Vyvanse Capsule 30mgPOqam Yesmethylphenidate Ritalin Tablet 5–15mgPObid–tid Yes
ATTENTION-DEFICIT DISORDER AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Chapter 1 Pharmacology for Technicians 33
ANTICONVULSANT AGENTSEpilepsy:Aneurologicdisorderdefinedasparoxys-
mal,recurringseizures.Itinvolvesdisturbancesofneuronalelectricalactivity.Seizurescanbepartial,generalized(grandmal,petitmal,myoclonic,andatonic),orstatusepilepticus.
MOA:Blockthefiringofneurotransmitters, resultinginaraisedlevelofdepolarizationAdverse reactions: Sedation and loss of cognitiveprocesses
Contraindications/cautions: Hypersensitivity to TCAs,bonemarrowdepression
Special Considerations
• Monotherapyispreferredoverpolytherapyunlessthepatientisnotrespondingtomonotherapy.
• A large number of drug interactions may occurwith anticonvulsants because of induction orinhibition.
• Divalproexshouldbe takenwithwater,notwithcarbonateddrinks.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* CONTROLLED SUBSTANCE
carbamazepine Tegretol Tablet,chewabletablet,suspension
Upto1200mg/dayin3–4divideddoses
No
clonazepam Klonopin Tablet 1.5–20mgPOqd Yesdiazepam Valium Injection,IV,oralliquid,tablet Dosagevaries Yesdivalproex Depakote Tablet 15–60mg/kgdayindivideddoses
2–3timesperdayNo
fosphenytoin Cerebyx IM,IV 4–6mgPe/kg/dayIM/IVqd–tid
No
gabapentin Neurontin Capsule,suspension 900–3600mgPOqd Nolacosamide Vimpat Tablet,IV 100–200mgPO/IVbid Nolamotrigine Lamictal Tablet 100–500mgPOqd Nolevetiracetam Keppra Tablet 1000–3000mgPOqd Nooxcarbazepine Trileptal Oralliquid,tablet 600–2400mgPOqd Nophenobarbital Luminal Tablet,solution,IM,IV 100mgPOqd;dosagevariesfor
injectableformsYes
phenytoin Dilantin Tablet,capsule,suspension,IV 200–400mgPOqd Nopregabalin Lyrica Capsule 150–600mgPOqd Noprimidone Mysoline Tablet,suspension 250–1000mgPOqd Notiagabine Gabitril Capsule 32–56mgPOqd Notopiramate Topamax Tablet 200mgPObid Novalproicacid Depakene Capsule,syrup,IV Upto1750mgPOqd Nozonisamide Zonegran Capsule 100–600mgPOqd No
ANTICONVULSANT AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
ANTIPARKINSON AGENTSParkinson Disease: A progressive disorder of
the basal ganglia associated with a loss or defi-ciency of dopamine; symptoms include tremors,muscle rigidity, loss of balance, hypokinesia andbradykinesia
MOA:PotentiateCNSdopaminergicresponsesAdverse reactions:Nausea,vomiting, cardiacarrhyth-mias, drowsiness, postural hypotension, insomnia,constipation,diarrheaContraindications/cautions:Abruptwithdrawal,depression
Special Considerations
• Therapyisaimedatsymptomaticrelief.• Numerous side effects may occur, resulting in a
continualchangeoftherapy.• Alcoholshouldbeavoided.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
amantadine Symmetrel Capsule,syrup 100mgPObidapomorphine Apokyn Injection(SC) 0.2–0.6mLSCprnbenztropine Cogentin Tablet,IM,IV 1–2mgPO/IM/IVqhsbromocriptine Parlodel Tablet,capsule 10–30mgPOqdentacapone Comtan Tablet 200mgPOperdose
ANTIPARKINSON AGENTS
Continued
34 Mosby’s Review for the Pharmacy Technician Certification Examination
MULTIPLE SCLEROSIS AGENTSMultiple sclerosis:Anautoimmunediseaseinwhich
themyelinsheathsaroundnervesdegenerate,re-sultinginalossofmusclesandeyesight
MOA:VariabledependingonagentAdverse reaction:PhotosensitivityContraindication/caution:Hypersensitivitytoalbumin
Special Considerations
• Productsrequirespecialstorage.• Copaxone is given daily, Betaseron is adminis-
teredeveryotherday,andAvonexisadministeredonceweekly.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
levodopa–carbidopa Sinemet Tablet IndividualizeddosePOtid–qidlevodopa–carbidopa–entacapone Stalevo Tablet 1tabPOq3–8hpramipexole Mirapex Tablet 0.5mg–1.5mgPOtidrasagiline Azilect Tablet 1mgPOqdropinirole Requip Tablet 3–6mgPOtidrotigotinetransdermalsystem Neupro Transdermal 4–6mg/24hq24hselegiline Eldepryl Tablet 5mgPObidtolcapone Tasmar Tablet 100mgPOtidtrihexyphenidyl † Capsule,elixir,tablet 6–10mgPOqddivtid
ANTIPARKINSONIAN AGENTS—cont’d
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
dalfampridine Ampyra Tablet 10mgpoq12hglatirameracetate Copaxone Injection,SC 20mgSCqdinterferonb-1a Avonex Single-dosevial,SC 30mcgIMqwkinterferonb-1b Betaseron SCinjection 0.25mgSCqodmitoxantrone Novantrone IV 12mg/m2IV3q3mo
EXAMPLES OF MULTIPLE SCLEROSIS AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†NotavailableasaBrandedDrug
ALZHEIMER DISEASE AGENTSAlzheimer disease: A chronic progressive disease
resulting in memory loss, confusion, impairedjudgment, personality changes, disorientation,andalossoflanguageskills
MOA:Reversiblybindtoandinactivateacetylcholin-esterase(cholinesteraseinhibitor)
Adverse reactions:Nausea,vomiting,diarrheaContraindications/cautions: Cardiac conduction defects,asthma, or chronic obstructive pulmonary disease(COPD)Special consideration:Nodrugscanreversethecogni-tiveabnormalitiesofAlzheimerdisease.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
donepezil Aricept Tablet 5–23mgPOqhsgalantamine † Oralliquid,tablet 8–12mgPObidmemantine Namenda Tablet 10mgPObidrivastigmine Exelon Capsule,oralliquid 3–6mgPObid
ALZHEIMER DISEASE AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Notavailableasabrandeddrug.
Chapter 1 Pharmacology for Technicians 35
CONDITIONS AND TREATMENTS FOR THE RESPIRATORY SYSTEM
Asthma: Characterizedby reversible smallairwayobstruction, progressive airway inflammation,and increasedairwayresponsiveness frombothendogenous and exogenous stimuli; symptomsincludewheezing,dyspnea,andcoughing
Bronchitis:Aconditioninwhichthelungs’defensemechanisms have been destroyed by cigarettesmoke,occupationaldusts,fumes,environmentalpollution,orbacterialinfection;characterizedbyacoughthatproducesapurulent,green,orblood-soakedsputum
Emphysema:Destructionofalveoli,walls,orairsacsofthelungs,resultinginanobstructionoftheair-flow on expiration; may be caused by cigarettesmoke, air pollution, occupational exposure, orgeneticfactors
Cystic fibrosis: Characterizedbyanincreasedsecre-tionofviscousmucusresultsinhypoxiaandcanbefatal
BRONCHODILATORSIndications:Airwayobstruction,COPD,reversiblebron-chospasmsassociatedwithbronchitisandemphysemaMOA: Cause the b2 receptors to relax the smoothmuscles,resultinginadecreaseofbronchospasmsAdverse reactions:CNSstimulation,whichmayresultin nervousness, tremors, anxiety, nausea, palpita-tions,tachycardia,arrhythmiasContraindications/cautions:Ischemicheartdisease,hyper-tension,seizuredisorders
Special Considerations
• Patientsmayovermedicate themselves tocontroltheirasthma.
• Ipratropium solution needs to be protected fromlight.
• Salmeterolneedstobestoredatroomtemperatureandprotectedfromfreezingtemperaturesanddirectsunlight.
• A salmeterol canister should be stored with thenozzleenddown.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
albuterol ProventilHFA,ProAirHFA,VentolinHFA
Aerosol,capsule,solution,syrup,tablet,inhaler
2puffsinhaledq4–6h
epinephrine PrimateneandBronkaidMist,Adrenalin,Epi-Pen
SC,IM,IV 0.3–0.5mgSC/IMq20min33dosesprn
formoterolfumarate Foradil Capsule 1capinhaledq12hipratropium AtroventHFA Inhaler,nasalspray 2puffsinhaledqidipratropium–albuterol Combivent Aerosol 1–2puffsinhaledqidlevalbuterol XopenexHFA Inhaler 2puffsinhaledq4–6hprnpirbuterol Maxair Inhaler 1–2puffsinhaledq4–6hprnsalmeterol SereventDiskus Inhaler,inhalantdisks 50mcginhaledq12hterbutaline † Injection,tablet 2.5mgPOtid;max15mg/qdtiotropium SpirivaHandihaler Powderedcapsuleplacedina
Handihaler1capinhaledqd
BRONCHODILATORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Notavailableasabrandeddrug.
XANTHINE DERIVATIVESIndications: Used to treat lung disease that is unre-sponsivetoothermedications;usedasabronchodi-lator in reversible airway obstruction caused byasthma,chronicbronchitis,oremphysemaMOA:Reversebronchospasmassociatedwithantigensandirritants;improvecontractilityofdiaphragm
Contraindications/cautions:Pepticulcerdisease,seizuredisorders,arrhythmias
Special Considerations
• Bloodlevelsneedtobemaintainedat8to20mcg/m.• Theophylline may interact with macrolide and
fluoroquinoloneantibiotics.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
aminophylline † Tablet,liquid,IM,IV 380–760mg/dayPO/IVdivq6–8htheophylline Uniphyl,Theo-24,Elixophyllin Capsule,tablet,solution 300–600mg/dayPOdivq6–8h
XANTHINE DERIVATIVES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Notavailableasabrandeddrug.
36 Mosby’s Review for the Pharmacy Technician Certification Examination
LEUKOTRIENE INHIBITORSIndications: Prophylaxis and long-term treatment ofasthmaMOA: Block the effects of leukotrienes, resulting inblocking of tissue inflammatory responses such asedema
Adverse reactions:Headache,severeasthmaContraindication/caution:HepaticdiseaseSpecial consideration:PatientsusingSingulairmustbeolderthan6yearsofage.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
montelukast Singulair Tablet 10mgPOqpmzafirlukast Accolate Tablet 20mgPObidzileuton ZyfloCR Tablet 1200mgPObid
LEUKOTRIENE INHIBITORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
CORTICOSTEROIDSMOA:Stimulateadenylatecyclaseandinhibitinflam-matorycellsAdverse reactions:Inhaled corticosteroids:Oral candidiasis, irritationandburningofthenasalmucosa,hoarseness,drymouthOral corticosteroids: Facial hair on women, breast de-velopmentinmen,“buffalohump”or“moonface,”edema,weightgain,andeasybruising
Contraindications/cautions: Unhealed nasal surgery ortraumawound,unhealednasalseptalulcer,tubercu-losisinfectionSpecial considerations:Long-termoraldosingneedstobetaperedofftoavoidnightmares.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
beclomethasone BeconaseAQ Inhaler 1–2sprays/nostrilbiddexamethasone † Solution,tablet 0.75–0.9mg/dayPOdivq6–12hflunisolide † Inhaler 2sprays/nostrilbid–tidfluticasone Flovent,Flonase Inhaler 2sprays/nostrilqdfluticasone–salmeterol Advair Inhaler 1puffinhaledbidmethylprednisolone Medrol Tablet 7.5–60mgPOqd–qodmometasonefuroate Nasonex Nasalspray 2sprays/nostrilqdprednisolone Orapred,Pediapred Oralliquid,tablets 40–60mg/dayPOdivqd–bid33–10daysprednisone † Oralliquid,tablet 40–60mg/dayPOdivqd–bid33–10daystriamcinolone NasacortAQ Inhaler 1–2spraysineachnostrilqd
CORTICOSTEROIDS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Notavailableasabrandeddrug.
MAST CELL STABILIZERSMOA:InhibitinflammatorycellsIndications:Prophylaxis;hasnouseinanacuteattackAdverse reactions:Patientsusingcromolynmayexperi-enceanunpleasanttasteafterinhalation,hoarseness,drymouth,andstuffynose.Contraindications/cautions:Patientsyoungerthan2yearsofage,arrhythmias
Special Considerations
• Airwaypassagesmustbeopenbeforeuse;there-fore,abronchodilator isusedfirst inconjunctionwithmastcellstabilizers.
• Patientcomplianceisanobstaclebecauseofdosingfourtimesperday.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
cromolyn Gastrocom Oral† 200mgPOqid
MAST CELL STABILIZER
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Cromolynisavailableasanasalspray(Nasalcrom),nebulizersolution,andoralsolution.
Chapter 1 Pharmacology for Technicians 37
MUCOLYTIC AGENTSMOA:Breakapartglycoprotein, resulting ina reduc-tionofviscosityandeasiermovementandremovalofsecretions
Contraindications/cautions:Inadequatecough,upperGIbleedAdverse reaction: Acetylcysteine has an unpleasantodorandtastethatmaycausenoncompliance.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
fluticasone–salmeterol AdvairDiskus Inhalation 1puffinhaledbidbudesonide–formoterol Symbicort Inhalation 2puffsinhaledbid
LONG-ACTING BRONCHODILATOR/STEROID INHALER
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
TUBERCULOSIS AGENTSTuberculosis is a slow, progressive respiratory dis-
ease with symptoms of weight loss, fever, nightsweats,malaise,andlossofappetite.Amajorissuewithtuberculosisispatientcompliancebecauseofthelengthoftherapyandnumberofmedicationsa patient may be taking. Asymptomatic patientswillreceiveisoniaziddailyfor12months;patientswith clinical symptoms are treated with at leasttwomedications.
MOA: Bactericidal; inhibit lipid and nucleic acidsynthesisAdverse reactions: Hypersensitivity reactions, epigas-tricdiscomfortContraindications/cautions:Acutehepaticdisease,tyramine-containingfoods,histamine-containingfoodsSpecial consideration:Patientsshouldavoidalcohol.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
acetylcysteine † Solution 3–5mLof20%solutioninnebulizertid–qiddornasealfa Pulmozyme Solution 2.5mginnebulizerqd
MUCOLYTIC AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
cycloserine Seromycin Capsule 500–750mgPOqddivbid–qidethambutol Myambutol Tablet 15–25mg/kg/dayisoniazid(INH) Laniazid,Nydrazid Tablet 5mg/kg/dayisoniazid–pyrazinamide–rifampin Rifater Tablet 1tabletqdayisoniazid–rifampin Rifamate Tablet 2capsPOqdofloxacin Floxin IV,tablet 200–400mgPOq12hrifampin Rifadin Capsule,IV 10mg/kg/dayrifapentine Priftin Tablet 150mgPOtwiceweeklyfor2monthsfollowed
byonceamonthfor4monthsstreptomycin — Injection,IV 500mg–1gadministeredIMthreetimesa
weekforfirst3months
TUBERCULOSIS AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
38 Mosby’s Review for the Pharmacy Technician Certification Examination
SMOKINGSmoking increases the risk of heart disease, COPD,and stroke.Acute risks include shortness of breath,aggravation of asthma, impotence, infertility, and
increased serum carbon monoxide concentration.Smokingcessationresultsinareducedriskoflung,laryngoesophageal, oral, pancreatic, bladder, andcervicalcancerandcoronaryarterydisease.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
bupropion Zyban Tablet 150mgPObid37–12wk RXnicotine NicodermCQ,Nicotrol,
NicotrolNS,Nicorette,Transdermalpatch,gum,
spray,tabletApplyonepatchdaily;6–16cartridges
inhaleddaily;2mgPOq1–2h36wkOTC
varenicline Chantix Tablet 1mgPObid311wk RX
EXAMPLES OF SMOKING CESSATION AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
CONDITIONS AND TREATMENTS FOR THE DIGESTIVE SYSTEM
Gastritis: A stomach mucosal irritation and inflam-mation that can be linked to stress, medications,infection, autoimmune disease, alcohol, bile re-flux, Helicobacter pylori infection, or NSAID useand is characterized by belching, nausea, vomit-ing,bloating,andaburningsensation
Gastroenteritis: Aninflammationoftheliningoftheintestines causedbyavirus,bacteria,orparasitethat has symptoms of diarrhea, abdominal pain,vomiting, headache, fever, chills, and loss of ap-petite
Gastroesophageal reflux disease (GERD): Charac-terizedbyradiatingburningorchestpainandthepresenceofanacidtaste
Ulcers: Disorders of the upper GI tract caused byexcessive acid secretion. Ulcers may be catego-rizedasgastriculcers,whicharelocalexcavations
ofthegastricmucosaoccurringmoreofteninmenfrom the Western hemisphere. Duodenal ulcersoccur in the duodenum of the intestine and areusually caused by hypersecretion of acid. Stressulcersdevelopfromthebreakdownofthenaturalmucosalresistancefromseverephysiologicstresscausedbyanillness.
ANTACIDSMOA: NeutralizestomachacidtopreventrefluxAdverse reactions: Constipation,diarrheaContraindications/cautions: GI obstruction, hypercalce-mia,hypophosphatemia
Special Considerations
• Increasedfrequencyofadministrationmayresultinpoorpatientcompliance.
• Reducestheeffectivenessoftetracycline• AvailableOTC
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
aluminumhydroxide † Tablet,liquid 320–1280mgPOqid OTCaluminumhydroxide–
magnesiumhydroxideMaalox,Mylanta Tablet,liquid 10–20mLPOqidprn OTC
magnesiumhydroxide MilkofMagnesia Tablet,liquid 30–60mLPOqd OTC
ANTACIDS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Chapter 1 Pharmacology for Technicians 39
H2 ANTAGONISTSMOA: Block gastric acid and pepsin secretion fromhistamine,gastrin,certainfoods,andcaffeine;cholin-ergic stimulation through competitive inhibition atH2receptorsofthegastricparietalcellsAdverse reactions:Constipation,drowsinessContraindications/cautions: Hepatic or renal impair-ment,elderlypatients,chronicpulmonarydisease
Special Considerations
• Bedtimedoseisextremelyimportantintherapy.• Druginteractionsincludeaspirin,alcohol,caffeine,
andcoughandcoldpreparations.• AvailableOTCinlowerdoses• FamotidineIVshouldbestoredatroomtemperature.• Reconstituted oral suspension can be stored at
roomtemperatureandexpiresin30days.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
cimetidine TagametHB(OTCformavailable) Tablet 1tabPOprnnizatidine Axid(OTCformavailable) Tablet,capsule 150mgPObidranitidine Zantac(OTCformavailable) Tablet 150mgPObidfamotidine Pepcid(PepcidAC;OTCformavailable) Tablet,suspension,IM,IV 20–40mgPOqhs
H2 ANTAGONISTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
PROTON PUMP INHIBITORSIndications: Gastroesophageal reflux disease, erosiveesophagitis; takenwithotheragents intreatmentofH. pyloriMOA:InhibittheparietalcelladenosinetriphosphatepumpAdverse reactions:Diarrhea,dehydration
Contraindications/cautions: Long-term use, high dose,hypomagnesemia
Special Consideration
• Capsules may be opened and the contentsplacedinapplesauceifthepatienthasdifficultyswallowing.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* AVAILABLE OTC
dexlansoprazole Dexilant Capsule 30mgPOqd34wkesomeprazole Nexium Capsule 20mgPO/NGqd34–8wklansoprazole Prevacid Capsule,oralpowderpackets 15mgPO/NGqd38wk Yesomeprazole Prilosec Capsule 20mgPO/NGqd34–8wk Yespantoprazole Protonix Tablet,IV 20–40mgPO/NGqd34–8wkrabeprazole Aciphex Tablet 20mgPOqd34–16wk
PROTON PUMP INHIBITORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
COATING AGENTSMOA:Formaprotectivecoatoverulceragainstgastricacid,pepsin,andbilesalts
Adverse reactions:ConstipationContraindications/cautions:Renalfailure,GIobstruction
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* AVAILABLE OTC
alginicacid Gaviscon Tablet,chewabletablet,liquid 15–30mLPOqdprn Yessucralfate Carafate Tablet,liquidsuspension 1gPObid–qid No
COATING AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Crohn disease: Acongenitaloracquiredchronicin-flammationofthecoloncharacterizedbyabdomi-nalpain,weightlossanddiarrhea
Ulcerative colitis: A congenital or acquired chronicinflammation of the large intestine characterizedbysymptomsofrectalbleedingandpain
40 Mosby’s Review for the Pharmacy Technician Certification Examination
ANTIINFLAMMATORY AGENTSMOA: Unknown but exerts local antiinflammatoryeffectsAdverse reactions:Nausea,vomiting,headacheContraindications/cautions: Salicylates, influenza, vari-cella or febrile viral infection for patients youngerthantheageof20years
Special Considerations
• Sulfasalazine is contraindicated in patients whoareallergictosulfadrugsandaspirin.
• Bindstoirontablets• The patient needs to be kept hydrated, and the
drugshouldbetakenaftermeals.• Stainurineorange-yellowandpermanentlystain
softcontactlensesyellow
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
mesalamine Rowasa,Asacol,Pentasa Suppository,enema,tablet,capsule Dosagevariesdependingondosageformsulfasalazine Azulfidine Tablet,liquid 2g/dayPOdivqid
ANTIINFLAMMATORY AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
GENERIC NAME BRAND NAME INDICATION DOSAGE FORM DOSAGE*
azathioprine Imuran Crohndisease Tablet 100–250mgPOqdbalsalazide Colazal Ulcerativecolitis Capsule 2.25gPOtid38–12wkinfliximab Remicade Crohndisease IV 5mg/kgIV31duringwk0,2,6olsalazine Dipentum Ulcerativecolitis Capsule 500mgPObidpancrelipase † Exocrinepancreaticinsufficiency Capsule 500–2500lipaseunits/kgPOwith
mealsorsnacks
OTHER TREATMENTS FOR CROHN DISEASE AND ULCERATIVE COLITIS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Diarrhea: Loose, watery, and frequent stool and isconsideredchronic (long term) if it continues formorethan4weeks
Adverse reactions: Constipation, respiratory depres-sion,drowsinessContraindications/cautions: Pseudomembranous colitis,severevolumedepletion
Special Considerations
• Diarrheamayleadtodehydrationoftheindividual.• May mask more serious conditions, including
malabsorptionofdrugsandnutrients
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* AVAILABLE OTCCONTROLLED SUBSTANCE
attapulgite Kaopectate Liquid,tablet 30mLPOq30–60minprn Yes Nobismuthsubsalicylate PeptoBismol Tablet,caplet,liquid 2tabsor30mLPOq30–60min Yes Nodiphenoxylatewith
atropineLomotil Tablet,liquid 1–2tabsPObid-qidprn Yes
loperamide Imodium,ImodiumAD(OTC)
Caplet,capsule,liquid
4mgPO31dose;then2mgPOaftereachloosestool
Yes No
ANTIDIARRHEALS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Chapter 1 Pharmacology for Technicians 41
Constipation: Theresultoflow-fiberdiets;decreasedcolon content, increased colon pressure, anddecreasedpropulsivemotility
Emollients, Lubricants, and Saline Laxatives
MOA: Emollient laxativesdrawwater into thecolon,resultinginbowelevacuation
Adverse reactions:Nausea,vomiting,diarrheaContraindications/cautions: Fecal impaction, appendici-tis,GIobstruction
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
dioctylcalciumsulfosuccinate Surfak Tablet,capsule,liquid 1capPOqdprn OTCdocusatesodium Colace Tablet,capsule,microenema 50–300mg/dayPOdivqd–bidprn OTCmineraloil † Solution 15–45mLPOdivq8–24h OTCmagnesiumhydroxide MilkofMagnesia Liquid 30–60mLPOqdprn OTC
EMOLLIENTS, LUBRICANTS, AND SALINE LAXATIVES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Stimulant Laxatives
MOA: IncreasegutactivityfrommucosalstimulationAdverse reactions: Diarrhea,allergic reactions suchashives,andperipheralswelling
Contraindications/cautions: GIobstruction,elderlyuse
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
bisacodyl Dulcolax Tablet,suppository 1–3tabsPOqdprn;1suppprqdprn OTCsenna Senokot Tablet,syrup,granules 2–4tabsPOqhsprn OTC
STIMULANT LAXATIVES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Bulk-Forming Laxatives
MOA: Increasefiberinthediet,resultinginintestinalperistalsisAdverse reactions: Abdominalcramps,diarrhea,nausea
Contraindications/cautions: Acute abdomen, appendici-tis,fecalimpactionSpecial considerations/cautions:Consideredthesafesttouse;patientsshoulddrinkplentyofwater
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* RX OR OTC
methylcellulose Citrucel,FiberTrim Tablet,powder 1scoopPOqd–tidprn OTClactulose † Solution 15–30mLPOqd–bid RXpsylliumhydrophilicmucilloid Metamucil Powder 3.4gPOqd–tidprn OTC
BULK-FORMING LAXATIVES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Bowel Evacuant Laxatives
Indication: BowelcleansingbeforeGIexaminationMOA:IncreaseosmolarityofbowelfluidsAdverse reactions: Anaphylaxis,electrolyteimbalance,seizuresContraindications/cautions: Toxiccolitis,GIobstruction,intestinalperforation
Special Considerations
• Thepatientshouldfastforatleast3hoursbeforeadministration.
• Eight ounces should be taken every 10 minutesuntil4Lisconsumed.
Example: polyethylene glycol–electrolyte solution(e.g.,GoLYTELYorNuLYTELY)
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
lubiprostone Amitiza Capsule 24mcgPObidpolyethyleneglycol GoLYTELY,NuLYTELY,Colyte Powder 8ozq10minuntilclear
BOWEL EVACUANT LAXATIVES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
42 Mosby’s Review for the Pharmacy Technician Certification Examination
ANTIEMETICSIndication: Used to treat side effect of nausea, whichmaybeassociatedwithvariousmedicationsMOA: Inhibit the impulse going from the chemo-triggerzonetothestomachAdverse reaction:DrowsinessContraindication/caution: CongenitallongQTsyndrome
Special Considerations
• Phenothiazines may cause hypotension and mustbeusedcautiouslyinchildrenbecauseofthepoten-tialforoverdosage,resultinginseizures.
• Promethazine suppositories need to be refriger-atedandprotectedfromlight.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE
chlorpromazine † Tablet,capsule 10–25mgPOq4–6hprndimenhydrinate Dramamine Tablet,chewabletablet,
oralsolution1–2tabsPOq4–6hprn
granisetron † Tablet,IV 2mgPO31dose;then1mgPOq12h32doses;10mcg/kgIV31dose
hydroxyzineHCl † Tablet,IM 25–100mgq4–6hprnmeclizine Antivert,Bonine Tablet 25–100mg/dayPOdivbid–tidmetoclopramide Reglan IM,IV 1–2mgIM/IV31doseondansetron Zofran Tablet,IV Dosagesmayvaryprochlorperazine † Tablet,capsule 5–10mgPOq6–8hpromethazine † Tablet,IM,IV 12.5–25mgPO/IM/IVq4–6htrimethobenzamide Tigan Capsule,IM 300mgPO/IMtid–qid
ANTIEMETICS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
ANTIFLATULENT AGENTSIndications: Flatulence,gastricbloating,postoperativegaspainsMOA: Reducesurfacetension,resultingingasbubblesbeingreleasedmoreeasilyAdverse reaction:Diarrhea,nauseaContraindications/cautions: Intestinal perforation, GIobstructionExamples:Simethicone(Gas-X,Mylicon,Phazyme)
ANTIOBESITY AGENTSObesity:Males:25%oftotalbodyweightoverideal
bodyweightFemales:35%oftotalbodyweightoverideal
bodyweight
MOA: UnknownAdverse reactions: CNSstimulation,dizziness,fatigue,insomnia,drymouth,nausea,abdominaldiscomfort,constipation,hypertension,palpitations,arrhythmiasContraindications/cautions: Pulmonary hypertension,hyperthyroidism,glaucoma
Special Considerations
• Allarecontrolledsubstances,exceptXenical.• Bothfederalandstatecontrolledsubstanceregula-
tionsmustbefollowedregardingprocessing,fill-ing,andrecordkeeping.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE* CONTROLLED SUBSTANCE
diethylpropion † Tablet 25mgPOtidprnmeals Yesphentermine AdipexP Tablet 37.5mgPOqd Yesorlistat Xenical,Alli Capsule Takeduringor½hpc No
ANTI-OBESITY AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Chapter 1 Pharmacology for Technicians 43
CONDITIONS AND TREATMENTS FOR THE URINARY SYSTEM
Diuretics: Maintain balance of water, electrolytes,acids,andbasesinthebody
THIAZIDE DIURETICSIndications: Adjunctivetherapyincardiovasculardis-eases,suchashypertensionMOA: Promote sodium and water excretion in theurine,resultinginlowersodiumlevelsinbloodves-selsandareductioninvasoconstriction
Adverse reactions: Hypokalemia,hypomagnesemia,hy-peruricemia, hyperglycemia, hypercalcemia, photosensitivityContraindications/cautions: Hypersensitivity to sulfon-amides,anuria,renalorhepaticimpairmentSpecial consideration: Patientsmaybeadvisedtotakepotassiumsupplementsortoaddbananasororangestotheirdiet.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
hydrochlorothiazide † Tablet 12.5–200mgPOqd
THIAZIDE DIURETIC
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
LOOP DIURETICSIndications: Adjunctivetherapyincardiovasculardis-eases,hypertensionMOA: InhibitreabsorptionofsodiumandchlorideintheascendingloopofHenleanddistalrenaltubules,resultinginurinaryexcretionofwaterAdverse reactions: Low levels of sodium, chloride,magnesium,calcium,potassium
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
bumetanide † Tablet,injection 0.5–2mgqdethacrynicacid Edecrin Tablet,injection 25–100mgdivqd–tidfurosemide † Tablet,oralsolution,IM,IV 40–120mgdivqd–bidtorsemide Demadex Tablet,IV 20–200mgqd
LOOP DIURETICS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
POTASSIUM-SPARING DIURETICSIndications: Adjunctive therapy in cardiovascular is-sues,hypertensionMOA: Exchangeofsodiumexcretedinurinetoreturn-ingpotassiumtothebodyAdverse reactions: Hyperkalemia, arrhythmias, gyne-comastiainmales
Contraindications/cautions: Anuria, renal impairment,hyperkalemiaSpecial consideration: Should be avoided in patientstakingangiotensin-convertingenzyme(ACE)inhibi-torsowingtopotassium-sparingeffect
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
amiloride † Tablet 5–10mgPOqdspironolactone Aldactone Tablet 25–200mgPOqdtriamterene Dyrenium Capsule 100mgPObid
POTASSIUM-SPARING DIURETICS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Contraindications/cautions: Anuria, hepatic coma, elec-trolyteimbalances
Special Considerations
• Diureticsshouldbetakenearlyinthedaytoavoidnocturia(frequenturinationduringthenight).
• Discolored furosemide tablets or solution shouldbediscarded.
44 Mosby’s Review for the Pharmacy Technician Certification Examination
COMBINATION DIURETIC PRODUCTSIndications: Adjunctive therapy in cardiovascular is-sues,hypertensionAdverse reactions: Hyperkalemia;patientstakingMax-zidemayexperienceachangeintheirurinecolortoblue-green
Contraindications/cautions: Anuria,renalimpairmentSpecial consideration: Should not be given to patientstakingACEinhibitors
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
bisoprolol–hydrochlorothiazide Ziac Tablet 1tabPOqdspironolactone–hydrochlorothiazide Aldactazide Tablet 1–4tabPOdivqd–bidtriamterene–hydrochlorothiazide Dyazide,Maxzide Capsule,tablet 1–2cap(tab)POqd
COMBINATION DIURETIC PRODUCTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
a-BLOCKERSBenign prostatic hypertrophy: An enlargement of
theprostateofamanasheages,resultingindif-ficulturination
MOA: Relaxsmoothmuscles,especiallyintheprostatictissue,resultinginareductionofurinarysymptoms
Adverse reactions: Headache,orthostatichypotension,dizzinessContraindications/cautions: Hepatic impairment, cata-ractsurgery
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
alfuzosin Uroxatral Tablet 10mgPOqddoxazosin Cardura Tablet 1–8mgPOqdprazosin Minipress Capsule 0.5–1mgPObidtamsulosin Flomax Tablet 0.4mgPOqdterazosin Hytrin Capsule,tablet 1–5mgPOqhs
a-BLOCKERS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
cinacalcet Sensipar Tablet IndividualizedosePObid–qiddarbepoetin Aranesp Injection IndividualizedoseSC/IVepoetinalfa Epogen,Procrit Injection,IV IndividualizedoseSC/IVirondextran InFeD Injection,IV 0.5mLIM/IVastestdosesevelamer Renagel Tablet 800–1600mgPOtid
RENAL DISEASE AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
flutamide † Capsule 250mgPOq8hgoserelin Zoladex Implant 3.6mgSCq28days34dosesleuprolide Eligard Implant 7.5mgSCqmomegestrol MegaceES Oralliquid,tablet 625mgPOqdnilutamide Nilandron Tablet 150mgPOqd330d
DRUGS USED TO TREAT PROSTATIC CARCINOMAS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Chapter 1 Pharmacology for Technicians 45
MISCELLANEOUS TREATMENS FOR URINARY CONDITIONSUrinary tract infections: Presence of bacteria in
the urinary tract with localized symptoms thatinclude blood in the urine, fever, and burningsensation
Urex or Hiprex (Methenamine)
Indication: UTIMOA: BactericidalAdverse reactions: Nausea,dyspepsia,dysuria,rashContraindications/cautions: Renal impairment, hepaticinsufficiency,dehydration
Special Considerations
• Citrus products and antacids should be avoidedwhenthismedicationistaken.
• Sulfonamidesarecontraindicated.
Pyridium or Azo-Standard (Phenazopyridine)
Indication: DysuriaMOA: ProducestopicalanalgesiaAdverse reactions: Urinediscoloration,rash,pruritusContraindications/cautions: Glomerulonephritis,uremia,renalimpairmentSpecial consideration: Shouldbe takenwithanantibi-oticfor2days
Ditropan (Oxybutynin)
Indication: OveractivebladderMOA: AntagonizesacetylcholineatmuscarinicreceptorsAdverse reactions: Drymouth,dizziness,somnolence,constipationContraindications/cautions: Urinary retention, gastricretention,uncontrolledangle-closureglaucoma
Detrol (Tolterodine)
Indication: AntagonizesacetylcholinereceptorsMOA: AnticholinergicAdverse reactions: Drymouth,headache,constipation,abdominalpainContraindications/cautions: Uncontrolled angle-closureglaucoma,gastricretention,urinaryretention
CONDITIONS AND TREATMENTS FOR THE CARDIOVASCULAR SYSTEM
DYSRHYTHMIA
Dysrhythmia,formerlyreferredtoasanarrhythmia,isanirregularheartbeatresultingfromamalfunctionofthecardiacconductionsystem• Atrialflutter• Atrialfibrillation• Bradycardia:Abnormallyslowheartrate• Tachycardia:Abnormallyrapidheartrate
Membrane-Stabilizing Agents
MOA: Slow the movement of ions into the cardiaccells,resultinginareductionoftheactionpotentialAdverse reactions: Nausea,vomiting,dizzinessContraindications/cautions: Cardiogenic shock, second-orthird-degreeatrioventricular(AV)block
Special Considerations
• Procainamideandquinidineareextremelysimilarandhavebeeninterchangedintherapy.
• Lidocaine is drug of choice for emergency IVtherapy.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
disopyramide Norpace Capsule 150mgPOq6hflecainide Tambocor Tablet 5–300mgPOdivq8–12hlidocaine Xylocaine IV 1–4mg/minIVinfusionprocainamide † Tablet,capsule,IM,IV 1–6mg/minIVmexiletine † Tablet 200mgPOq8hpropafenone † Tablet 150–300mgPOq8hquinidine † Tablet,IM,IV Dosagevariesbycondition
MEMBRANE-STABILIZING AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
46 Mosby’s Review for the Pharmacy Technician Certification Examination
Antiarrhythmics
MOA: PreventthereleaseofvarioustransmittersandprolongtheactionpotentialAdverse reactions: Hypotension, bradycardia, mentaldepression,decreasedsexualability
Contraindications/cautions: Cardiogenic shock, second-orthird-degreeAVblock,pregnancySpecial considerations: IV amiodarone must be mixedinaglasscontainerwithD5W.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
amiodarone Cordarone Tablet,IV 200–600mgPOqddronedarone Multaq Tablet 400mgPObidsotalol Betapace Tablet 80–160mgPOq12h
ANTIARRHYTHMICS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Calcium Channel Blockers
MOA: Prevent movement of calcium ions throughslow channels, resulting in a reduction through theAV node, reduction in sinoatrial (SA) node action,andrelaxationofcoronaryarterysmoothmuscleAdverse reactions: Bradycardia,hypotension,heartblock,cardiacfailure,constipation,headache,dizziness
Contraindications: Second- or third-degree AV block,atrialfibrillationSpecial consideration: Diltiazem must be stored in alight-resistantcontainer.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
diltiazem † Capsule,tablet,IM,IV 30–90mgqiddiltiazem CardizemCD Capsule 180-360mgqddiltiazem CardizemLA Caplet 180-360mgqdverapamil CalanSR,Verelan Tablet,capsule 180–480mg/dayPOdivqd–bid
CALCIUM CHANNEL BLOCKERS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
CONGESTIVE HEART FAILUREThe pumping ability of the heart is unable to meetthemetabolicneedsofthebody’stissues,resultingintheheartpumpinglessbloodthanitreceives;bloodaccumulatesinthechambersoftheheart.
Cardiac Glycosides
Lanoxin (Digoxin)MOA: Increasestheforceofcontraction;increasestheeffectiverefractoryperiodoftheAVnode;andaffectstheSAnodethroughdirectstimulation
Adverse reactions: Nausea,vomiting,arrhythmiasContraindications: Ventricular fibrillation, ventriculartachycardia,sicksinussyndrome
Special Considerations
• Concernfordigoxintoxicity• Asymptomofdigoxin toxicity isseeingagreen-
bluehalo.
Chapter 1 Pharmacology for Technicians 47
Angiotensin-Converting Enzyme (ACE) Inhibitors
MOA: Inhibit the conversion of angiotensin I toangiotensin II. Lower quantities of angiotensin IIincrease plasma renin activity and reduce aldoste-ronesecretion.Adverse reactions: A dry, unproductive cough; dizzi-ness occurs during the first few days of therapy;angioedemaandpossibleposturalhypotension
Contraindications/cautions: ACE inhibitor angioedemahistory,hereditary,idiopathic,pregnancy
Special Considerations
• ACE inhibitors have a potassium-sparing effect;therefore, one must be aware of possibility ofhyperkalemia.
• Shouldbeavoidedinpatientsreceivinglithium
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
benazepril Lotensin Tablet 5–20mgPOqdcaptopril Capoten Tablet 12.5–50mgPOtidenalapril Vasotec Tablet 2.5–20mgPObidfosinopril † Tablet 10–40mgPOqdlisinopril Prinivil,Zestril Tablet 5–20mgPOqdperindopril Aceon Tablet 4–16mgPOqdquinapril Accupril Tablet 5–20mgPObid
ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Angiotensin II Receptor Antagonists (ARBs)
MOA: BlocktheactionofangiotensinIIatitsreceptorsAdverse reactions: Angioedema,coughContraindications/cautions: Pregnancy, renal artery ste-nosis,renalorhepaticimpairment
Special consideration: Ifpatientispregnant,medicationmustbediscontinuedimmediatelyorfetalorneona-talmorbidityormortalitymayoccur.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
candesartan Atacand Tablet 32mgPOqdvalsartan Diovan Capsule 40–160mgPObid
ANGIOTENSIN II ANTAGONISTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
MYOCARDIAL INFARCTIONTheheartmuscledoesnotreceiveenoughoxygenbe-causeofareducedbloodsupply,andmusclecellsdie.Myocardialinfarction(MI)canbepreventedthroughbehavior modifications, which include eliminatingsmoking,controllingdiabetes,reducinghypertension
through diet and lifestyle modification, exercisingthreetimesperweek,reducingcaloriestomeetidealweight, decreasing alcohol consumption, reducingcholesterol and triglycerides, and using aspirin ther-apyifappropriate.Beta-blockersareusedandshouldbetaperedappropriatelyaftertheoccurrenceofMI.
48 Mosby’s Review for the Pharmacy Technician Certification Examination
Beta-Blockers
MOA: Blockresponsetobetastimulation,resultinginareductionintheheartrate,myocardialcontractility,bloodpressure,andmyocardialdemandAdverse reactions: Heart depression, bronchoconstric-tion,impotence,fatigue,depression,bradycardia
Contraindications/cautions: Sinus bradycardia, second-orthird-degreeAVblock,heartfailureSpecial consideration: Discontinuationshouldbetaperedtoreducethelikelihoodofangina.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
atenolol Tenormin Tablet,IV 100mg/dayPOdivqd–bidcarvedilol Coreg Tablet 25mgPObidmetoprolol Lopressor Tablet 100mgPObidpropranolol Inderal Tablet,capsule 180–240mg/dayPOdivtid–qid
BETA-BLOCKERS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
ANGINA PECTORISChestpainisexperiencedbecauseofanimbalancebe-tweenoxygensupplyanddemand;maybeintheformofstableangina,variantangina,orunstableangina.
Nitrates
MOA: Relax vascular smooth muscle, resulting inlowervenousreturnandcardiacfillingandthereforedecreasedtensionincardiacwallsandcoronaryves-selsaredilated
Adverse reactions: Orthostatichypotension,flushingContraindications/cautions: Cardiomyopathy, constric-tivepericarditis,anemia
Special Considerations
• Nitroglycerininhalantisflammable.• Nitroglycerininjectionneedstobeprotectedfrom
light.• Medication should not be stopped abruptly but
shouldbetapered.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
isosorbidedinitrate Dilatrate-SR,Sorbitrate Tablet,capsule 40–80mgPOqd–bidisosorbidemononitrate Imdur Tablet 30–60mgPOqamnitroglycerin Nitrostat,Nitrobid,Nitro-Dur,
Transderm-NitroSpray,tablet,capsule,ointment,
injection,IV,transdermalpatch0.3–0.6mgSLq5min;0.5–2inch
topicalq4–6h;0.2–0.4mg/hpatchqd
NITRATES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Calcium Channel Blockers (CCBs)
MOA: Inhibitcalciumionsfromentering“slowchan-nels”ofthevascularsmoothmuscleandthemyocar-dium,resultinginrelaxationofthecoronarysmoothmuscleandcoronaryvasodilationandadecreaseinoxygendemandAdverse reactions: Constipation,drowsiness
Contraindications/cautions: Sicksinussyndrome,second-orthird-degreeAVblock,hypotension
Special Considerations
• Shouldbetakenwithfood• Caffeineshouldbelimitedinquantity.• Nifedipine liquid-filled capsules need to be pro-
tectedfromlight.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
diltiazem DilacorXR Capsule,tablet,IV 120–240mgPOqdnicardipine † Capsule,injection 20–40mgPOtidnifedipine Procardia Capsule,tablet 10–20mgPOtidverapamil CalanSR,Verelan,Covera-HS Tablet,capsule,IV 80–120mgPOtid
CALCIUM CHANNEL BLOCKERS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Chapter 1 Pharmacology for Technicians 49
Beta-Blockers
MOA: Slowtheheartrate,causingdecreasedmyocar-dialcontractilityandloweredbloodpressure,result-inginadecreaseinoxygendemand.Adverse reactions: Bradycardia, hypotension, fatigue,dizziness
Contraindications/cautions: Sinus bradycardia, second-orthird-degreeAVblock,heartfailureSpecial considerations/cautions:• Maymasksymptomsofhypoglycemiaandhyper-
thyroidism• Medicationshouldbetaperedoffwhentherapyis
discontinued.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
atenolol Tenormin Tablet,IV 50–200mgPOqdmetoprolol Lopressor,ToprolXL Tablet,IV 50–200mgPObidnadolol Corgard Tablet 40–80mgPOqdpropranolol Inderal Capsule,tablet,solution 80–320mgPOdivbid–qid
BETA-BLOCKERS
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
ranolazine Ranexa Extended-releasetablet 500–1000mgPObid
RECENTLY APPROVED AGENT FOR ANGINA
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
HYPERTENSIONSystolicpressure(cardiacoutput)greaterthan140mmHganddiastolicpressure(totalperipheralresistance)greater than 90 mm Hg; the disease does not havesymptoms.
Diuretics
MOA: ReducetotalperipheralresistanceAdverse reaction:Possiblehypokalemiadependingonagentused
Contraindications/cautions: Anuria, hepatic coma, elec-trolyteimbalanceSpecial consideration: Shouldbetakenearlyinthedaytoeliminatethepossibilityofnocturia
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
chlorothiazide † Tablet,IM,IV 250–500mgPOqd–bidfurosemide Lasix Tablet,oralsolution†,IM†,IV† 10–40mgPObidhydrochlorothiazide † Tablet 12.5-50mgPOqdspironolactone Aldactone Tablet 25–50mgPOqdtriamterene–hydrochlorothiazide Dyazide,Maxzide Capsule,tablet 1–2tabsPOqd
DIURETICS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Calcium Channel Blockers
MOA: Dilatearterioles,resultinginareductionintotalperipheralresistance,energyconsumption,andoxy-genrequirement
Adverse reactions: Drowsiness,peripheraledema,head-ache,palpitationsContraindications/cautions: Severe coronary artery dis-ease,severeaorticstenosis,congestiveheartfailure
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
amlodipine Norvasc Tablet 5–10mgPOqdfelodipine Plendil Tablet 2.5–10mgPOqdisradipine DynaCircCR Capsule 5mgPOqdnicardipine CardeneSR Capsule 30–60mgPObidnifedipine ProcardiaXL Capsule 30–90mgPOqdverapamil CalanSR,Verelan,Covera-HS Tablet,capsule,IV 180–480mg/dayPOdivqd–bid
Calcium Channel Blockers
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
50 Mosby’s Review for the Pharmacy Technician Certification Examination
Angiotensin-Converting Enzyme (ACE) Inhibitors
MOA: BlockACEtopreventtheconversionofangio-tensinItoangiotensinII,resultinginareductionintotalperipheralresistanceandimprovedelasticityofarteries
Adverse reactions: Cough,hypotension,dizziness,fatigueContraindications/cautions: ACE inhibitor angioedema(history,hereditaryoridiopathic),pregnancySpecial consideration: Ifpatientispregnant,medicationmustbediscontinuedimmediatelyorfetalorneona-talmorbidityormortalitymayoccur.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
benazepril Lotensin Tablet 20–40mgPOqdcaptopril Capoten Tablet 25–50mgPObid–tidenalapril Vasotec Tablet 10–40mgPOqdfosinopril † Tablet 20–40mgPOqdlisinopril Prinivil,Zestril Tablet 10–40mgPOqdquinapril Accupril Tablet 20–80mgPOqdperindopril Aceon Tablet 4–8mgPOqdramipril Altace Capsule 2.5–20mgPOdivqd–bidtrandolapril Mavik Tablet 2–4mgPOqd
ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Angiotensin II Receptor Antagonists
MOA: BindtoangiotensinIIreceptorsandblockvaso-constrictiveeffectsofthearteriesAdverse reactions: URI,fatigue,dyspepsiaContraindications/cautions: Pregnancy, renal or hepaticimpairment
Special consideration: Ifpatientispregnant,medicationmustbediscontinuedimmediatelyorfetalorneona-talmorbidityormortalitymayoccur.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
azilsartan Edarbi Tablet 80mgPOqdlosartan Cozaar Tablet 25–100mgPOdivqd–bidtelmisartan Micardis Tablet 20–80mgPOqdvalsartan Diovan Capsule 80–320mgPOqd
ANGIOTENSIN II RECEPTOR ANTAGONISTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Beta-Blockers
MOA: Block beta-receptor response to adrenergic re-sponse, resulting in decreased heart rate, myocardialcontractibility,bloodpressure,andmyocardialresponse
Adverse reactions: Bradycardia,hypotension,fatigueContraindications/cautions: Sinus bradycardia, second-orthird-degreeAVblock,heartfailureSpecial consideration: Avoidabruptcessation.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
acebutolol Sectral Capsule 400–800mgPOqdatenolol Tenormin Tablet 50–100mgPOqdmetoprolol Lopressor,ToprolXL Tablet 50–200mgPObid
BETA-BLOCKERS (CARDIOSELECTIVE)
Chapter 1 Pharmacology for Technicians 51
Central Nervous System Agents
MOA: Stimulate a2-adrenergic responses in the brainandreducesympatheticoutflowfromthevasomotorcenterinthebrain,resultingindecreasedheartrate,cardiacoutput,andtotalperipheralresistance
Adverse reactions: Drowsiness, fatigue, depression,fluidretentionContraindications/cautions: Avoid abrupt withdrawal;cardiovasculardisease,severecoronaryarterydisease
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
carvedilol Coreg Tablet 6.25mgPObidlabetalol Trandate Tablet 200–400mgPObidnadolol Corgard Tablet 40–80mgPOqdpropranolol Inderal Capsule,tablet,solution,IV 80–240mgPObidtimolol † Tablet 10–20mgPObid
BETA-BLOCKERS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
clonidine Catapres Tablet,patch,IV 0.1–0.3mgPObidguanfacine Tenex Tablet,liquid 1–3mgPOqhsmethyldopa † Tablet,oralsuspension,IV 250–500mgPObid
CENTRAL NERVOUS SYSTEM AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Peripherally Acting Agents
MOA: Blockastimulationtoperipheralnerves,result-inginvasodilationandhypotension
Adverse reaction:HypotensionContraindications/cautions: Hypotension,hepaticimpair-ment,cataractsurgery
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
doxazosin Cardura Tablet 1–4mgPOqdprazosin Minipress Capsule 3–7mgPObidterazosin Hytrin Capsule 1–5mgPOqhs
PERIPHERALLY ACTING AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Vasodilators
MOA: Reduce arteriole smooth muscle, resulting inlowerperipheralresistance
Adverse reactions: Tachycardia, palpitations, flushing,headacheContraindications/cautions: Coronaryarterydisease,mi-tralvalverheumaticheartdisease
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
fenoldopam Corlopam IV 0.1–1mcg/kg/minIVhydralazine † Tablet 10–50mgPOqidminoxidil † Tablet 10–40mgPOqd
VASODILATORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
52 Mosby’s Review for the Pharmacy Technician Certification Examination
Combination Products
MOA: Anadditiveeffecttolowerbloodpressureandreducethenumberofsideeffects
Special consideration: Fewersideeffectsbecausemedi-cationsareinlowerdosages
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
amlodipine–benazepril Lotrel Capsule 1capPOqdbenazepril–hydrochlorothiazide LotensinHCT Tablet 1tabPOqdenalapril–hydrochlorothiazide Vaseretic Tablet 1tabPOqdirbesartan–hydrochlorothiazide Avalide Tablet 1tabPOqdlosartan–hydrochlorothiazide Hyzaar Tablet 1tabPOqdtelmisartan–hydrochlorothiazide MicardisHCT Tablet 1tabPOqdtrandolapril–verapamil Tarka Tablet 1tabPOqdvalsartan–hydrochlorothiazide DiovanHCT Tablet 1tabPOqd
COMBINATION AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
STROKEInterruptionoftheoxygensupplytoaspecificareaof
thebraincausedbyaruptureorobstruction(clot)ofthebloodvessel,resultinginalossofconscious-ness;complicationsmayincluderetinopathy,neu-ropathy, vascular problems, or kidney damage;maybeischemicorhemorrhagic
Transient ischemic attack (TIA): Atemporaryreduc-tioninoxygenandbloodinaportionofthebrain
Anticoagulants
MOA: Preventproperclot formationwhilemaintain-ingadequatecoagulationAdverse reactions: Bleeding; urine may turn red-orange;fecesmayturnredorblackContraindications/cautions: Hypersensitivity to porkproducts,activemajorbleeding,thrombocytopenia
Special Considerations
• Warfarininjectionmustbeprotectedfromlight.• Patients should avoid foods rich in vitamin K if
warfarinistaken.• Manydruginteractionsoccurwithwarfarin.Me-
phytonisgiventotreatanoverdoseofwarfarin.• Blood clotting must be monitored through pro-
thrombin time or international normalized ratiotesting.
• HeparinistobegiveneitherIVorsubcutaneouslybutneverintramuscularly.
• Protamine sulfate is used to treat overdoses ofheparin.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
argatroban Argatroban Injection 2mcg/kg/minIVbivalirudin Angiomax IV 0.75mg/kg/IV31dose;then1.75mg/kg/hupto
4h;thenmaycontinue0.2mg/kg/hIVupto20hdabigatran Pradaxa Tablet 150mgPObiddalteparin Fragmin SC 5000unitsSCqd35–10denoxaparin Lovenox SC 1mg/kgSCq12hfondaparinux Arixtra Injection 2.5mgSCqd35–9dheparin Heparin IV 5000unitsSCq8–12hlepirudin Refludan IV 0.15mg/kg/hIVtinzaparin Innohep SC 175units/kgSCqdwarfarin Coumadin Tablet 2–10mgPOqd
ANTICOAGULANTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Chapter 1 Pharmacology for Technicians 53
Antiplatelet Agents
MOA: Interfere with chemical reactions that causeplateletstoclotAdverse reactions: Nausea,dyspepsia,diarrhea,abdom-inalpain
Contraindications/cautions: Active bleeding, GI bleed,intracranialhemorrhageSpecial consideration: Havebeenshowntohavedimin-ishedefficacyinpoormetabolizers
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
abciximab ReoPro IV 0.125mcg/kg/minIV312halteplase Activase IV 0.9mg/kgIVover60minaspirin — Tablet 75–325mgPOqdclopidogrel Plavix Tablet 75mgPOqdeptifibatide Integrilin IV 2mcg/kg/minIVreteplase Retavase IV 10unitsIV32tenecteplase TNKase IV 30–50mgIVdependingonbodyweightticlopidine Ticlid Tablet 250mgPObidtirofiban Aggrastat IV 0.1mcg/kg/mininfusion
ANTIPLATELET AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
HYPERLIPIDEMIAHyperlipidemiaisanelevationofoneormoreofthelipoproteinlevels.• Bloodcholesterollevelsper100mLofblood:
• 240mg:atrisk• Lessthan200mg:desirable• 135mg:moredesirable
• Bloodlow-densitylipoproteinlevelsper100mLofblood:• 160mg:highrisk• 139to159mg:borderlinerisk• Lessthan139mg:desirable
Atherosclerosis: Abuildupfattymaterialsorplaque,usuallycholesterol,inthearterialbloodvessels
HMG-COA Reductase Inhibitors
MOA: Inhibittheenzymethatcatalyzestherate-limitingstepincholesterolsynthesisAdverse reactions: GI upset, headache, muscle pain,feverContraindications/cautions: Hepaticdisease,elevatedliverfunctiontest(LFT)results,pregnancy,breastfeedingSpecial consideration: LFTsshouldbeconductedevery6months.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
atorvastatin Lipitor Tablet 10–80mgPOqdfluvastatin Lescol Capsule 20–80mgPOdivqd–bidlovastatin Mevacor Tablet 10–80mgPOqpmpravastatin Pravachol Tablet 10–80mgPOqdrosuvastatin Crestor Tablet 5–40mgPOqdsimvastatin Zocor Tablet 5–40mgPOqpm
HMG-COA REDUCTASE INHIBITORS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Fibric Acid Derivatives
MOA: UnknownAdverse reactions: Headache, nausea, vomiting, diar-rhea,skinrash,alterationinliverandkidneyfunction
Contraindications/cautions: Gallbladderdisease,hepaticorrenalimpairment
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
fenofibrate TriCor Capsule 145mgPOqdgemfibrozil Lopid Tablet,capsule 600mgPObid
FIBRIC ACID DERIVATIVES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
54 Mosby’s Review for the Pharmacy Technician Certification Examination
Bile Acid Sequestrants
MOA: Formanonabsorbablecomplexwithbileacidsintheintestine
Adverse reactions: NauseaandvomitingContraindication/caution:Biliaryobstruction
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
cholestyramine Questran(Light) Powder 4–8gPObidcolesevelam Welchol Tablet 3750mgPOqdcolestipol Colestid Tablet,granule 2–16g/dayPOdivqd–qid
BILE ACID SEQUESTRANTS
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
amlodipine–atorvastatin Caduet Tablet 1tabPOqdezetimibe Zetia Tablet 10mgPOqdezetimibe–simvastatin Vytorin Tablet 1tabPOqpmniacin–lovastatin Advicor Tablet 1–2tabsPOqhs
OTHER CHOLESTEROL-LOWERING AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
NARCOTIC AND OPIOID ANALGESICSIndication: AcuteandchronicpainMOA: Narcotic and opioid analgesics interact withspecificreceptorsitesandhaveaneffectontheCNS.The body produces endorphins, enkephalins, anddynorphins. These substances are released by thebrainafterthereleaseofstimulicausedbypain.Anincreaseinthelevelofpainresultsinanincreaseinthereleaseofthesesubstances.ThereisadecreaseinthenervetransmissiontotheCNS,resultinginade-crease in thesensationofpain.Narcoticandopioidanalgesics respond to the same receptors as endor-phins,enkephalins,anddynorphins.Adverse reactions: Respiratory depression, constipa-tion,mentalconfusion,nausea,vomiting
Contraindications/cautions: Elderly patients, hepatic orrenalimpairment,drugabusehistory
Special Considerations
• Haveapotentialfortoleranceandaddiction• All opiates are controlled substances, and one
mustadheretobothfederalandstatelawsregard-ing processing, dispensing, and maintainingproperrecordsofcontrolledsubstances.
• Increasedfluidintakeisrecommendedalongwithstoolsoftenerstocombatconstipation.
• May provide analgesia, sedation, euphoria, ordysphoriaduringpainmanagement
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*CONTROLLED SUBSTANCE
SCHEDULE
acetaminophenwithcodeine
TylenolwithCodeine
Capsule,tablet,IM,IV,SC,elixir
15–60mgcodeinePOq4–6hprn III
butorphanol(nasalspray)
† Nasalspray,IM,IV 0.5–2mgIVq3–4h;1mginonenostrilq3–4h
IV
codeine † Tablet 15–60mgPOq4–6hprn IIfentanyl Duragesic Transdermalpatch,IV 25–100mcg/hpatchq72h;
50–100mcgIVq1–2hprnII
hydrocodone/homatropine
† Tablet 1tabPOq4–6hprn III
hydrocodone–acetaminophen
Lortab,Vicodin Tablet 2.5–10mghydrocodonePOq4–6hprn
III
hydromorphone Dilaudid Tablet,syrup,liquid,IM,IV,SC
2-8mgPOq3–4hprn;1–4mgSC/IM/IVq3–6h
II
meperidine Demerol Tablet,syrup,IM,IV,SC 50–150mgPO/SC/IMq3–4h IImethadone Dolophine Oralconcentrate,oral
solution,tablet2.5–10mgPOq8–12hprn II
morphine MSContin Tablet 15–30mgPOq8–12h II
NARCOTICS AND OPIOIDS
Chapter 1 Pharmacology for Technicians 55
NONNARCOTIC ANALGESICS
Nonsteroidal Antiinflammatory Drugs (NSAIDs)Indications: Conditionsforwhichantipyretic,analgesic,andantiinflammatoryagentsareused
MOA: Inhibitprostaglandinsynthesis,preventingthesensitizationofthepainreceptorsContraindications/cautions: Aspiring-orNSAID-inducedasthma,aspirintriad,pregnancyinthethirdtrimesterAdverse reactions: Stomachirritation,drowsiness,nau-sea,abdominalcramps,jaundice,rash
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*CONTROLLED SUBSTANCE
SCHEDULE
oxycodone OxyContin Capsule,liquid,tablet 10mgPOq12h IIoxycodone-
acetaminophenPercocet,Tylox Tablet,capsule 5–10mgoxycodonePOq6h II
oxycodone–aspirin Percodan Tablet 1tabPOq6hprn IIpentazocine Talwin Tablet,IM,IV,SC 30mgIM/IV/SCq3–4hprn IVpentazocine–
naloxoneTalwinNx Tablet 1–2tabsPOq3–4hprn IV
NARCOTICS AND OPIOIDS—cont’d
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
diclofenac Cataflam Tablet 50mgPOtiddiclofenac–misoprostol Arthrotec Tablet 1tabPObid–qiddiflunisal † Tablet 500mgPOq12hetodolac † Tablet,capsule 200–400mgPOq6–8hfenoprofen Nalfon Tablet,pulvule 200mgPOq4–6hprnflurbiprofen Ansaid,Ocufen Tablet,ophthalmicdrops 50–100mgPObid–tidibuprofen MotrinIB,Advil Tablet,liquid,drops,
chewabletablets300–800mgPOtid–qid
indomethacin † Capsule,IV,suppository 25mgPOtidketorolac † Tablet,IM,IV 10mgPOq4–6hnabumetone † Tablet 1000–2000mgPOqddivqd–bidnaproxen Anaprox,Naprosyn,
NaprelanTablet,caplet 250–500mgPOq12h
oxaprozin Daypro Caplet 1200mgPOqdpiroxicam Feldene Capsule 20mgPOqd
NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDs)
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Cyclooxygenase-2 Inhibitors
Indications: Rheumatoidarthritis,osteoarthritis,men-strualcramps,acutepainMOA: Blockcyclooxygenase-2(COX-2)enzymespro-ducedduringinflammation
Contraindications/cautions: Aspirin-orNSAID-inducedasthma,pregnancyinthethirdtrimesterAdverse effects:GIdistressandfluidretention
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
celecoxib Celebrex Capsule 200mgPOqd
CYCLOOXYGENASE-2 INHIBITOR
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
56 Mosby’s Review for the Pharmacy Technician Certification Examination
Aspirin
Indications: Conditions treated with analgesic, anti-pyretic, antiinflammatory, or antirheumatic agents.Low-doseaspirinisusedforitsantiplateleteffectstopreventMI.MOA: Reduce fever by increasing blood flow to theskinandinhibitingprostaglandinandthromboxanesynthesis.Adverse reactions: Stomachulceration,antiplateletag-gregation effects leading to bleeding, anemia, pro-longed pregnancy and labor, tinnitus, dizziness,headache,mentalconfusionContraindications/cautions: Aspirin-orNSAID-inducedasthma,aspirintriad,GIbleed,GIulcer
Special Considerations
• Should not be given to children who have beenexposedtoanyviralinfection,suchaschickenpox;mayresultinReyesyndrome
• Should not be given to patients who are takingwarfarin
Acetaminophen
Indications: Conditions treated with analgesics andantipyreticsMOA: MechanismhasnotbeenestablishedAdverse reactions: May increase bleeding in patientstaking warfarin; may damage liver and therefore
shouldnotbegiventopatientswithliverdiseaseoralcoholicsContraindications/cautions: Hepatic or renal impair-ment; limitation on daily alcohol intake. Cautionshould be noted when patient is taking multipleprescriptions or OTC medications because takingacetaminophenmayresultinoverdoseiftakenwithalcohol.Migraine headache:Causedbyadecreaseinserotoninlevels in thebody,resulting in thereleaseofneuro-peptides that travels to the meninges of the brain,resulting in dilation and an inflammation of thebloodvessels
Selective 5-HT Receptor Agonists
Indication: MigraineheadachesMOA: Stimulate serotonin receptors in the cerebraland temporal arteries, which causes vasoconstric-tion,which in turn inhibitsneural transmission, re-sulting in excessive vasoconstriction of the cranialarteriesAdverse reactions: Tinglingwarmsensation,chestdis-comfort,dizziness,vertigoContraindications/cautions: Uncontrolled hypertension,ischemicheartdisease,coronaryvasospasmSpecial consideration: Sumatriptaninjectionneedstobeprotectedfromlight.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
almotriptan Axert Tablet 6.25–12.5mgPO31doseeletriptan Relpax Tablet 20–40mgPO31dosefrovatriptan Frova Tablet 2.5mgPO31doserizatriptan Maxalt,MaxaltMLT Tablet 5–10mgPO31dosesumatriptan Imitrex Tablet,SCsolution,inhaler 25–100mgPOx1dose;4–6mgSC3
1dose;5–20mginonenostril31dosesumatriptan/naproxen Treximet Tablet 1tabPO31dosezolmitriptan Zomig Tablet 1.25–2.5mgPO31dose
SELECTIVE 5-HT RECEPTOR AGONISTS
MISCELLANEOUS MIGRAINE MEDICATIONSGENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
aspirin–butalbital–caffeine Fiorinal Tablet 1–2tabsPOq4hbutorphanolnasal † Nasalspray 1mginonenostrilq3–4hergotamine–caffeine Cafergot Tablet 1–2tabsPOq30minprn
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Chapter 1 Pharmacology for Technicians 57
AUTOIMMUNE MEDICATIONS
Disease-Modifying Antirheumatic Drugs (DMARDs)Indication: RheumatoidarthritisMOA: Inhibitlymphocytesandcytokineactivity
Adverse reactions: URIsymptoms,headache,rashContraindications/cautions: Active infection, concurrentlivevaccination,patients65yearsofageandolder
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
abatacept Orencia IV Dosagevariesbybodyweightadalimumab Humira Injection 40mgSCq2wkanakinra Kineret Injection 100mgSCq24hauranofin Ridaura Capsule 3mgPObidazathioprine Imuran Tablet 1–2.5mg/kg/dayPOdivqd–bidcyclophosphamide † Injection,IV,tablet 1.5–3mg/kgPOdailyetanercept Enbrel Injection 50mgSCqwkhydroxychloroquine Plaquenil Tablet 200–400mgPOqdinfliximab Remicade IV 3mg/kgIV31onwk0,2,6leflunomide Arava Tablet 10–20mgPOqdmethotrexate † Injection,IV,tablet 7.5–25mgPO/IMqwkpenicillamine Cuprimine Capsule 250–500mgPObid–tid
DISEASE-MODIFYING ANTIRHUEMATIC DRUGS (DMARDs)
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
CONDITIONS AND TREATMENTS FOR THE SKELETAL SYSTEMOsteoporosis: Thinning of bone tissue and loss of
bonedensityovertime
BISPHOSPHONATESIndication: OsteoporosisMOA: InhibitsboneresorptionbyosteoclastsAdverse reactions: Abdominalpain,acidregurgitation,nausea
Contraindications/cautions: Hypocalcemia,abnormalesoph-agealperistalsis
Special Considerations
• Itshouldbetaken30minutesbeforethefirstmeal,beverage,ormedicationoftheday.
• Themedicationshouldbetakenwith6to8ozofwatertoavoidesophagealburning.
• The patient should not lie down for at least30minutesaftertakingthemedication.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
alendronate Fosamax Tablet 10mg/dayor70mgweeklyalendronate1vitaminD FosamaxwithvitaminD Tablet 10mg/dayor70mgweeklyetidronate Didronel Tablet,IV 5–10mg/kgperdayibandronate Boniva Tablet Onetabletdailyrisedronate Actonel Tablet 5mg/dayor35mg/week
or150mg/monthtiludronate Skelid Tablet 400mgPOqd33mozoledronicacid Zometa IV 4mgIVq3–4wk
BISPHOSPHONATES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)
Evista (Raloxifene)Indication: OsteoporosisMOA: InhibitsestrogenreceptorsAdverse reactions: Hotflashes,infection,influenza-likesymptoms,arthralgiaContraindications/cautions: Thromboembolism,pregnancy,breastfeeding
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
raloxifene Evista Tablet 60mg/day
SELECTIVE ESTROGEN REPLACEMENT MODULATOR
GENERIC NAME
BRAND NAME
DOSAGE FORM DOSAGE*
denosumab Prolia Solution 650mgSCq6moteriparatide Forteo IV 20mgSCqd
OTHER BONE DISEASE AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
58 Mosby’s Review for the Pharmacy Technician Certification Examination
CONDITIONS AND TREATMENTS FOR THE ENDOCRINE SYSTEM
HYPOTHYROIDISM
Congenital hypothyroidism (cretinism) is an iodinedeficiencydiseasefoundinchildren.Thesymptomsin adults include apathy, decreased heart rate, anddepression.Symptomsinchildrenincludeshortstat-ure,thicktongue,possibleenlargedthyroid,loweredvoice pitch, myxedema, puffy face, reduced mentalacuity,andweightgain.
Hypothyroidism Agents
Indications: ThyroidreplacementtherapyAdverse reactions: Cardiotoxicityandhyperthyroidism
Contraindications/cautions: Thyrotoxicosis,acuteMI,adre-nalinsufficiency
Special Considerations:
• Patientsshouldundergothyroid-stimulatinghor-monetests.
• Levothyroxine has a narrow therapeutic index,which requires caution when switching betweendifferentgenericversionsoflevothyroxine.
• Levothyroxineinjectionneedstobeusedpromptlyafterreconstitution.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
levothyroxine Synthroid,Levothroid,Levoxyl Tablet,injection 100–125mcgPOqdliothyronine Cytomel Tablet 25–75mcgqdliotrix Thyrolar Tablet 1tabPOqdthyroid ArmourThyroid Tablet 60–120mgPOqd
HYPOTHYROIDISM AGENTS (MUST BE INDIVIUALIZED)
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
HYPERTHYROIDISM (GRAVES DISEASE)Hyperthyroidismisanexcessivesecretionofthyroidhormonesthatmaybecausedbythyroidnodules,anexcessiveiodineintake,oratumorcausingoverpro-ductionof thyroid-stimulatinghormone.Symptomsinclude decreased menses, diarrhea, exophthalmos,heatintolerance,nervousness,perspiration,tachycar-dia,andpossibleweightloss.
Hyperthyroid Agents
MOA:Therapy,surgeryAdverse reactions:Fever,sorethroat,unusualbleedingorbruising,headache,malaiseContraindications/cautions:Breastfeeding,pregnancyEXAMPLES OF HYPERTHYROID AGENTS
methimazole Tapazole Tablet 15–30mgPOqdpropylthiouracil *† Tablet 100–150mgPOqd
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nobrandnamedrugavailable;availableonlyasageneric.
Chapter 1 Pharmacology for Technicians 59
HORMONE REPLACEMENT THERAPY (HRT)Indication: Estrogenreplacementtherapyrelievessymp-toms of estrogen deficiency that include vasomotorinstability, drying and atrophy of vaginal mucosa,insomnia,irritability,andmoodchanges.MOA: Suppressfollicle-stimulatinghormonesecretionAdverse reactions: Nausea, bloating, weight gain,breast tenderness, breast cancer, possible break-throughbleeding
Contraindications/cautions: Undiagnosedvaginalbleed-ing,breastcancer,pregnancy
Special Considerations
• Allestrogenproductsshouldbedispensedwithapatientpackageinsert.
• Conjugatedestrogentherapyiscyclic.• WhereasEstradermandVivelleareappliedtwice
weekly,Climaraisappliedweekly.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
conjugatedestrogen Premarin Tablet,cream 0.3–1.25mgPOqdconjugatedestrogen–
medroxyprogesteronePrempro,Premphase Tablet 1tabPOqd
estradiol Estrace Tablet,cream 1–2mgPOqdestradiol–levonorgestrel Climara,ClimaraPro Patch 1patch13/wkestradiol–norethindrone Activella,CombiPatch Tablet,transdermalpatch 1tabPOqd;1patch23/wkestropipate † Tablet,cream 0.75–6mgPOqd
ESTROGENS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
PROGESTINSIndications: Treatmentofmenstrualdysfunction,suchasuterinebleeding,amenorrhea,dysmenorrhea,andendometriosisMOA: Inhibitluteinizinghormonesecretionbymeansofanegativefeedbackonthehypothalamicanteriorpituitaryaxis
Contraindications/cautions: Undiagnosedvaginalbleed-ing,breastcancer,genitalorgancancerAdverse reactions: Weight gain, depression, fatigue,acne,hirsutism
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE†
medroxyprogesterone Provera Tablet 5–10mgPOqd35–10daysnorethindrone Micronor Tablet 1tabPOqd
PROGESTINS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
ADDISON DISEASEAddison disease is a deficiency of glucocorticoidsandmineralocorticoidsthatistreatedwithcorticoste-roids.SymptomsofAddisondisease includedebili-tatingweakness,weight loss,hyperpigmentationofthe skin, reduced blood pressure, low sodium andglucoselevels,andhyperkalemia.
CUSHING DISEASECushing disease results from an overproduction ofsteroids or excessive administration of corticoste-roidsoveranextendedperiod.Symptomsincludeaprotruding abdomen and fat over the shoulderblades.
60 Mosby’s Review for the Pharmacy Technician Certification Examination
Corticosteroids
MOA: CombinewithsteroidreceptorsincytoplasmIndications: Arthritis, dermatitis, allergic reactions,asthma,hepatitis,systemiclupuserythematosus,in-flammatoryboweldiseaseforglucocorticoidreplace-ment inAddison disease or other forms of adrenalinsufficiencyContraindications/cautions:Diabetes,tuberculosis,affec-tivedisorders
Adverse reactions: Stomach irritation, hypertensionfrom sodium retention, slow wound healing, thin-ning of skin, peptic ulcer disease, increased infec-tions, reduced white blood cell function, truncalobesity, moon face, buffalo hump, hyperglycemia,hypokalemia, osteoporosis, alterations in mood,manic-depressivebehavior,cataracts
CORTICOSTEROID BRAND NAME EQUIVALENCY (mg) ANTIINFLAMMATORY POTENCY
betamethasone Diprolene 0.6 25.0cortisone Cortone 25.0 0.8dexamethasone Decadron 0.75 30.0hydrocortisone Hydrocortisone 20.0 1.5methylprednisolone Medrol 4.0 5.0prednisolone Pediapred 5.0 4.0prednisone Deltasone 5.0 3.0triamcinolone Aristocort 4.0 5.0
EQUIVALENCY OF CORTICOSTEROIDS COMPARED WITH THE DAILY SECRETION OF HYDROCORTISONE (20 mg)
TYPE OF EFFECT SIDE EFFECT
Cardiovascular HypertensionDermatologic Impairedwoundhealing,thinningoftheskin,petechiae,purpuraGastrointestinal Pepticulcerdisease,pancreatitisImmunesystem InfectionsandreductionofwhitebloodcellfunctionMetabolic Redistributionoffatdeposits,acne,hirsutism,growthsuppression,hyperglycemia,hypokalemia,
sodiumandwaterretentionMusculoskeletal Osteoporosis,vertebralcompressionNeuropsychiatric Alterationsinmood;manic-depressive,psychotic,suicidal,orschizophrenictendenciesOphthalmic Cataractsandglaucoma
SIDE EFFECTS OF CORTICOSTEROIDS
DIABETES• Gestational diabetes: Occurs during the second
and third trimester of pregnancy; can be treatedwithexercise,diet,andinsulin
• Type 1 diabetes (insulin-dependent diabetes mellitus [IDDM] or juvenile-onset diabetes):In-dividual’sbodyisunabletoproduceinsulin,soheorshebecomesinsulindependent.
• Type 2 diabetes (non–insulin-dependent diabe-tes mellitus [NIDDM] or adult-onset diabetes): Conditionthatoccursinindividualswhohaveanimpaired insulin secretion and are often insulinresistant; treatment includes medication andweightreductionthroughdietandexercise
• Secondary diabetes: Onsetcausedbytakingvari-ousmedications,suchasoralcontraceptives,beta-blockers,diuretics,calciumchannelblockers,glu-cocorticoids,andphenytoin
Oral Hypoglycemic Agents
Second-Generation SulfonylureasMOA: Promotereleaseofinsulinfromthebetacellsofthepancreas;andlowerbloodglucoselevelsAdverse reactions: Diarrhea, nausea, hypoglycemia,dizzinessContraindications/cautions: Diabetic ketoacidosis, neartermpregnancy,renalorhepaticimpairmentSpecial consideration: Adjuncttoexerciseanddiet
Enzyme Inhibitors
MOA: Inhibitintestinalwallenzymesthatconvertsac-charides intoglucose,resultingin loweringofpost-prandialhyperglycemiaAdverse reactions: Abdominal pain, diarrhea, andflatulence
Chapter 1 Pharmacology for Technicians 61
Contraindications/cautions: Patients with cirrhosis, in-flammatoryboweldisease, colonulceration, intesti-nalobstructionSpecial consideration: Mustbemonitoredevery3monthsfor1yearandthenperiodicallyasdirected
Biguanides
MOA: Decrease glucose production by the liver andimproveinsulinsensitivityAdverse reactions: Nausea, metallic aftertaste, weightloss
Contraindications/cautions: Renal dysfunction or dis-ease,metabolicacidosis,diabeticketoacidosisSpecial consideration: Needtobetitratedupwardoveraperiodofweeks
Glitazones
MOA: ImprovecellularresponsetoinsulinAdverse reactions: Increasedplasmavolume,elevatedhigh-densitylipoproteinlevelsContraindications/cautions: Type1diabetesmellitus,di-abeticketoacidosis
GENERIC NAME BRAND NAME AGENT TYPE DOSAGE FORM DOSAGE*
acarbose Precose Enzymeinhibitor Tablet 50–100mgPOtidglimepiride Amaryl Second-generationsulfonylureas Tablet 1–4mgPOqdglipizide Glucotrol,GlucotrolXL Second-generationsulfonylureas Tablet 5–10mgPOqdglyburide DiaBeta,Glynase,
MicronaseSecond-generationsulfonylureas Tablet 1.25–20mgPOqd
metformin Glucophage,GlucophageXR
Biguanide Tablet 850mgPObid
miglitol Glyset Enzymeinhibitor Tablet 50–100mgPOtidnateglinide Starlix Meglitinide Tablet 60–120mgPOtidbefore
mealsrepaglinide Prandin Meglitinide Tablet 0.5–4mgPOacpioglitazone Actos Glitazone Tablet 15–30mgPOqdSitagliptin Januvia DPP-4inhibitor Tablet 100mgPOqdpramlintide Symlin Amylinanalogue Injection 15mcgSCqac
Combination Productsglipizide–metformin Metaglip Tablet 1–2tabsPOqd–bidglyburide–metformin Glucovance Tablet 1–2tabsPObidrepaglinide–metformin PrandiMet Tablet Individualizedosebid–tid
HYPOGLYCEMIC AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Injectable Hypoglycemic Agents
MOA: VariabledependingontheclassofmedicationAdverse reactions: Hypoglycemia,blurryvision,hyper-sensitivity,hypertensionContraindications: Hypoglycemia
Comments
• Humulin insulincanbestoredat roomtempera-turefor1month.
• Humaloginsulinrequiresaprescription.• Regularinsulinistheonlytypeofinsulinthatcan
beusedIV.
GENERIC NAME BRAND NAME DURATION OF ACTION
exenatideinjection Byetta Longactinginsulindetemirinjection Levemir Longactinginsulininjection RegularIletinI Rapid
RegularIletinII RapidNovolinR Rapid
isophaneinsulin NPHIletinI IntermediateHumulinN Intermediate
isophaneinsulinsuspensionandinsulininjection Humulin70/30 Intermediateisophaneinsulinsuspensionandinsulininjection Humulin50/50 Intermediateinsulinglulisine Apidra Rapidinsulinzincsuspension;extendedlente HumulinUltralente Longactinginsulinanaloginjection Humalog Rapidinsulinglargine Lantus Longactingliraglutide(rDNAorigin) Victoza Longacting
INJECTABLE HYPOGLYCEMIC AGENTS
62 Mosby’s Review for the Pharmacy Technician Certification Examination
CONDITIONS AND TREATMENTS FOR THE REPRODUCTIVE SYSTEM
ORAL CONTRACEPTIVES
Indication: PreventpregnancyMOA: Suppressovulationbyinterferingwithproduc-tion of hormones that regulate the menstrual cycleandalterthecervicalmucus
Adverse reactions: Potential for heart attack, stroke,and thromboembolic disease. Other side effectsincludenausea,weightgain,breasttenderness,anddepression.Contraindications/cautions: Smokers, pregnancy, breastcancer,endometrialcancerSpecial consideration: Oralcontraceptivesmustbedis-pensedwithapatientpackageinsert.
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
estradiolvalerate–dienogest Natazia Tablet 1tabPOqdethinylestradiol–desogestrel Cyclessa,Desogen,Kariva,
Mircette,Ortho-CeptTablet 1tabPOqd
ethinylestradiol–drospirenone Yasmin,Yaz Tablet 1tabPOqdethinylestradiol–ethynodiol
diacetateDemulen Tablet 1tabPOqd321days(21daypack)or
1tabPOqd328days(28-daypack)ethinylestradiol–etonogestrel NuvaRing Ring Insertoneringvaginallyfor3weeks;
removeringanddispose;wait1weekandrepeat
ethinylestradiol–levonorgestrel Seasonique Tablet 1tabPOqd391daysandrepeatethinylestradiol–norelgestromin OrthoEvra Patch 1patchweeklyfor3weeks;stopfor
1weekandresumeethinylestradiol–norethindrone EstrostepFe,Femhrt,Loestrin
Fe,Ovcon,OrthoNovumTablet 1tabPOqd
ethinylestradiol–norgestimate OrthoTri-Cyclen,OrthoTri-CyclenLo
Tablet 1tabPOqd
ethinylestradiol–norgestrel Lo/Ovral,Low-Ogestrel Tablet 1tabPOqd
Emergency Contraceptiveslevonorgestrel PlanBOneChoice,NextStep Tablet 1tabPO31;1tabPOq12h32doses
Parenteralmedroxyprogesterone Depo-Provera Injection 150mgIMqmo
EXAMPLES OF ORAL CONTRACEPTIVES
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
CLASS DRUGS TYPE OF INTERACTION
Antibiotics Erythromycin,griseofulvin,penicillin,rifampin,tetracycline
Maydecreaseeffectivenessoforalcontraceptivefrominterferencewithenterohepaticcyclingofestrogen,resultinginafluctuationofhormonelevels
Anticonvulsants Tegretol,Dilantin,Mysoline,phenobarbital Decreasecontraceptiveactionfromincreasedmetabolismofhormones
Antifungals Diflucan,Nizoral,Sporanox MaydecreaseeffectivenessoforalcontraceptivesBenzodiazepines Dalmane,Halcion,Librium,Valium,Xanax Metabolismofbenzodiazepinemaybedecreased,
resultinginanincreaseinsideeffectsBronchodilator Theophylline Increasedsideeffectsoftheophyllineresultingfrom
decreasedtheophyllinemetabolismCorticosteroids Hydrocortisone,methylprednisolone,
prednisolone,prednisoneIncreasedeffectsfrominhibitionofmetabolismby
oralcontraceptivesLipid-loweringagents Atromid-S DecreasedoralcontraceptiveeffectTricyclicantidepressants Elavil,Tofranil Increasedsideeffectsoftricyclicantidepressants
EXAMPLES OF ORAL CONTRACEPTIVE INTERACTIONS
Chapter 1 Pharmacology for Technicians 63
GENERIC NAME BRAND NAME DOSAGE FORM DOSAGE*
sildenafil Viagra Tablet 1tabPOqdtadalafil Cialis Tablet 1tabPOqdvardenafil Levitra Tablet 1tabPOqd
ERECTILE DYSFUNCTION AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Erectile dysfunction Aman’sinabilitytoachieveormaintainanerectionduetoalackofbloodflowingtothepenis
ERECTILE DYSFUNCTION AGENTSMOA: Inhibitphosphodiesterasetype5,enhancingtheeffectsofnitricoxide–activatedincreaseincGMP
Adverse reactions: Headache,flushing,dyspepsia,visualContraindications/cautions: Patients with pulmonaryveno-occlusivedisease;patientstakingnitratesshouldnottakebecauseofpossibleMI
CONDITIONS AND TREATMENTS FOR THE INTEGUMENTARY SYSTEM
Psoriasis: Consistsofpatchesofred,scalyskin,usu-allyon theelbowsandknees;maybecausedbyillness,injury,oremotionalstress
PSORIASIS AGENTSMOA: RegulateskincellproductionandproliferationAdverse reactions: Skinirritation,burning,rash,pruritusContraindications/cautions: Hypercalcemia, vitamin Dtoxicity
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* SPECIAL CONSIDERATIONS
acitretin Soriatane Capsule 25–50mgPOqdalefacept Amevive Injection 15mgIMqwk312wkcalcipotriene Dovonex Cream,ointment Applybid Patientshouldwashhands
aftereachapplicationcyclosporine Neoral Capsule,oralliquid 2.5-4mg/kg/dayPO
divbidmethotrexate † Tablet,IM,IV 10–25mgPO/IMqwk Mayinhibitnormalcell
growthpimecrolimus Elidel Cream Applybidtacrolimus Protopic Ointment Applybid
PSORIASIS MEDICATIONS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
64 Mosby’s Review for the Pharmacy Technician Certification Examination
Acne vulgaris: Aninfectionofthesebaceousglandsthatmayproducepustules,papules, comedones,andscars
ACNE VULGARIS AGENTSMOA: Removekeratinocytes in thesebaceous follicleby loosening the horny cells at the mouth of theducts,resultingineasysloughing
Adverse reactions: Erythema,scaling,drynessContraindications/cautions: Photosensitivity, sunburn,eczemaSpecial consideration: Hands should be washed aftereachapplication.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* SPECIAL CONSIDERATIONS
adapalene Differin Gel Applyqhs Waterbased;causeslessirritationthanRetin-Aazelaicacid Azelex Cream Applybid Thinfilmshouldbeappliedtoaffectedarea
twiceperdayclindamycin-benzoyl
peroxideBenzaClin Gel Applybid
tretinoin Retin-A Cream,gel,lotion Applyqhs Avoidexposuretosun;handsshouldbewashedaftereachuse;maycausesevereirritation
tretinoin Renova Cream Applyqhs HasamoremoisturizingeffectthanRetina-Abenzoylperoxide Brevoxyl Lotion Applyqd–bid
ACNE VULGARIS AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Actinic keratoses: A small, rough spot occurringon skin that has been chronically exposed to thesunandgenerallymeasureinsizebetween2and6mmindiameter
ACTINIC KERATOSES AGENTSIndications: AntiproliferativeagentsforskincancerMOA:Interferewithacell’sabilitytoreproduce
Adverse reactions: Itching, burning, soreness, tender-ness,scaling,andswellingContraindications/cautions: Poor nutritional state, my-elosuppression,infectionSpecial consideration: May cause transient burning oftheskin
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* SPECIAL CONSIDERATIONS
aminolevulinicacid LevulanKerestick Topicalsolution Applyq8wkdiclofenac Solaraze Gel Applybid360–90daysfluorouracil Efudex Cream,solution Applybid2–4wk Properhandwashingshouldbefollowed;
avoiddirectsunlight;needstobedis-posedofproperlybecauseitisananti-neoplasticagent
ACTINIC KERATOSES AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Chapter 1 Pharmacology for Technicians 65
TOPICAL ANTIFUNGALSMOA: Prevent the synthesis of ergosterol, which isneededforfungalcellmembranes
Adverse reactions: Irritation, burning, stinging, pruri-tus; inhibit fungalcytochromeP450associatedwithazoledrugsContraindications/cautions: Noneidentified
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* SPECIAL CONSIDERATIONS
butenafine Mentax Cream Applyqd–bid37–14days Usedtotreatathlete’sfoot,jockitch,andringworm;useddailyfor4weeks
ciclopirox Loprox Cream,lotion Applybid34wk AvailableOTCclotrimazole Lotrimin,Mycelex Cream,lotion,vaginal,
trocheApplybid;1appqhs3
7nights;10mgpo53/day314days
AvailableOTC
clotrimazole–betamethasone
Lotrisone Cream,lotion Applybid
econazole † Cream Applyqdgriseofulvin † Tablet,capsule,oral
suspension375mgPOqd32–6wk Fungalinfectionsofthehair,skin,
andnails;avoidexposuretosun;takewithafattymeal
miconazole Monistat Cream,vaginal,IV,spray
Dosagevariesbaseduponcondition
OTC;usedtotreatvulvovaginalcandidiasis
nystatin Mycostatin Cream,ointment,oralsuspension,capsule
Applybid–tid Commonlyusedtotreatchildrenwithcandidiasis;patientsaretoldtoswishandswallow
nystatin–triamcinolone
† Cream,ointment Applybid
oxiconazole Oxistat Cream,lotion Applyqd–bid314dayssertaconazole Ertaczo Cream Applybid34wksulconazole Exelderm Cream Applyqd–bid33–4wkterbinafine Lamisil Cream,tablet 250mgPOqd32–12wk Takenorallyonceperdayfor
6weeksforfingernailinfectionsandfor12weeksfortoenailinfections;maybepulsedosed
tolnaftate Tinactin Liquid,powder,cream,solution
Applybid OTC
TOPICAL ANTIFUNGAL AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
66 Mosby’s Review for the Pharmacy Technician Certification Examination
TOPICAL CORTICOSTEROIDSMOA: Suppressthehypothalamic–pituitaryaxisIndications: Dermatitis,psoriasis,eczema,rashesContraindication/caution: NoneidentifiedAdverse reactions: Burning skin, contact dermatitis,pruritus
Special Considerations
• Creams and ointments should not be consideredinterchangeable.
• Topicalsshouldnotbeoccludedwithacovering.• A thin layer should be applied sparingly to the
affectedarea.• Corticosteroidsshouldnotbeusedformorethan
2weeks.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
amcinonide † Cream,lotion,ointment Applybid–tidbetamethasone0.05% Diprolene Cream,gel,ointment Applyqd–bidclobetasol0.05% Temovate Cream,ointment Applybiddesoximetasone0.25% Topicort Cream,ointment Applybiddiflorasone0.05% † Ointment Applybid–qidfluocinolone † Cream,ointment Applybid–qidfluocinonide0.05% † Cream,ointment,solution Applybid–tidhalobetasol0.05% Ultravate Cream,ointment Applyqd–bidhydrocortisonebutyrate Locoid Cream,ointment,solution Applybid–tidhydrocortisonevalerate Westcort Cream,ointment Applyqd–qidmometasone0.1% Elocon Ointment Applyqdtriamcinolone Kenalog Cream,lotion,ointment Apply32sectid–qid
TOPICAL CORTICOSTEROIDS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE*
bacitracin–neomycin–polymyxinB
TripleAntibiotic Ointment Applyqd–tid
clindamycin CleocinT Cream,gel,lotion,solution Applybiderythromycin † Gel,solution Applybidmafenide Sulfamylon Cream,topicalsolution Applyqd–bidmetronidazole MetroGel,MetroCream Gel,cream Applybidmupirocin Bactroban Ointment Applytid37–14daysneomycin–polymyxinB Neosporin Ointment Applyqd-tidsilversulfadiazine Silvadene Cream Applyqd–bid
TOPICAL ANTIBIOTICS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
Chapter 1 Pharmacology for Technicians 67
CONDITIONS AND TREATMENTS FOR THE OPHTHALMIC SYSTEM
Glaucoma:A chronic disorder characterized by ab-normallyhighinternaleyepressurethatdestroystheopticnerveandmaycauselossofvision.Threetypes of glaucoma exist: open-angle, narrow-angle,andsecondaryglaucoma.
GLAUCOMA AGENTSMOA: ReduceintraocularpressureAdverse reactions: Blurredvision,hyperemia,pruritusContraindications/cautions: OcularinflammationSpecial consideration: Drug treatment cannot cure thediseasebutcancontrolit.
GENERIC NAME BRAND NAME OPHTHALMIC DOSAGE FORMS DOSAGE* COMMENTS
apraclonidine Iopidine Solution 1–2gttineye(s)tidbetaxolol BetopticS Solution,suspension 1–2gttineye(s)bidbimatoprost Lumigan Solution 1gttineye(s)qpmbrimonidine AlphaganP Solution 1gttineye(s)tid Reducesfluidproductionintheeyebrinzolamide Azopt Solution 1gttineye(s)tid Shouldnotbetakenwithcarbonic
anhydraseinhibitorsdorzolamide Trusopt Solution 1gttineye(s)tid Bittertastemaybepresentafter
administrationlatanoprost Xalatan Solution 1gttineye(s)qpm Maycauselight-coloredeyesto
turnbrown;shouldbestoredintherefrigerator
timolol Timoptic,TimopticXE Solution 1gttineye(s)qd–bidtravoprost TravatanZ Solution 1gttineye(s)qpm
GLAUCOMA AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.
Conjunctivitis (pink eye):Anacuteinflammationoftheconjunctivathatiscausedbyviruses,bacteria,fungi,orallergies
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* CLASSIFICATION
alcaftadine Lastacaft Solution 1gttineye(s)qd Allergybacitracin † Ointment Applyineye(s)q3–4h Antibioticciprofloxacin Ciloxan Solution 1–2gttineye(s)q2hwhileawake;then
q4h312daysAntibiotic
cromolynsodium Crolom Solution 1–2gttineye(s)4–63day Mastcellstabilizercyclosporine Restasis Solution 1gttineye(s)q12h NSAIDdexamethasone † Ointment 1gttineye(s)tid–qid Corticosteroiddiclofenac Voltaren Solution 1gttineye(s)qid32wk NSAIDflurbiprofen Ocufen Solution Dosagevariesbasedoncondition NSAIDgatifloxacin Zymar Solution 1gttineye(s)q2hupto8332d;then
1gttqid35daysAntibiotic
gentamicin Garamycin Solution,ointment 1–2gttineye(s)bid–tid Antibioticketorolac Acular Solution 1gttineye(s)qid NSAIDlevofloxacin † Solution 1–2gttineye(s)q2hwhileawake;then
q4hwhileawake3 5daysAntibiotic
naphazoline NaphconA Solution 1–2gttineye(s)prn OTCdecongestantofloxacin Ocuflox Solution 1–2gttineye(s)q2–4h32days;then
1–2gttqid35daysAntibiotic
olopatadine Patanol Solution 1gttineye(s)bid Antihistaminesulfacetamide-
prednisoloneBlephamide Ointment,solution,
suspension2gttineye(s)q4hwhileawake Corticosteroid
sulfacetamidesodium Bleph-10 Ointment,solution 1–2gttineye(s)q2–3h37–10days Antibiotictobramycin-dexa-
methasoneTobradex Ointment,solution 1–2gttineye(s)q4–6h Corticosteroid
trifluridine Viroptic Solution 1gttineye(s)q2hwhileawakeuntilreepithelization;then1gttq4hwhileawakefor7days
Antiviral
OTHER OPHTHALMIC AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.NSAID,Nonsteroidalantiinflammatorydrug;OTC,overthecounter.
68 Mosby’s Review for the Pharmacy Technician Certification Examination
Otitis media: An infection of the middle ear oftencausedbyaninflammationoftheEustachiantube
GENERIC NAME BRAND NAME DOSAGE FORMS DOSAGE* COMMENTS
antipyrine-benzocaine † Solution 2–4gttinear(s)tid32–3days Analgesiccarbamideperoxide Debrox Solution 5–10gttinear(s)bid Waxdissolverneomycin–polymyxin
B–hydrocortisone
† Suspension,solution 4gttinear(s)tid–qid Antibiotic
OTIC AGENTS
*Pleasenotethatalldosagesareforadultsandexpressedinoraldosagesunlessotherwiseindicated.†Nolongeravailableasabrandeddrug.
CHEMOTHERAPY AGENTS
ALKYLATING AGENTS
MOA: Formirreversiblecross-linksinDNA,resultingincellsbeingunabletoreproduceAdverse reactions: Myelosuppression,hairloss,nausea,vomiting,appetite,weightlossContraindications: Bonemarrowdepression,pregnancyduringfirsttrimester,breastfeeding
ANTIBIOTICSMOA: Inhibit DNA-dependent RNA synthesis; delayorinhibitmitosisAdverse reactions:Myelosuppression,alopecia,nausea,vomitingContraindications/cautions: Impaired cardiac function,hepaticorrenalsuppression
ANTIMETABOLITESMOA: Participates as an “imposter” in essential cellreaction,resultinginnonfunctionalfunctionstopre-ventnormalfunctionsofkeyenzymesAdverse reactions: Myelosuppression,alopecia,nausea,vomiting,diarrheaContraindications/cautions: Myelosuppression,pregnancy,anemia
PLANT ALKALOIDSMOA: Prevent formation of functional spindle fibersneededforcelldivisionAdverse reactions: Neurotoxicity, myelosuppression,alopecia,nausea,vomiting,extravasation,anemiaContraindication/caution: Breastfeeding
GENERIC NAME BRAND NAME DOSAGE FORMS CLASSIFICATION
bleomycin Blenoxane IV,IM,SC Antibioticbusulfan Myleran Tablet Alkylatingchlorambucil Leukeran Tablet Alkylatingcisplatin Platinol IV,tablet Alkylatingcyclophosphamide Cytoxan Tablet,injection Alkylatingcytarabine Cytosar-U SC,IM,IV Antimetabolitedaunorubicin Cerubidine IV Antibioticdoxorubicin Adriamycin IV Antibioticepirubicin Ellence IV Antimetaboliteetoposide * Capsule,IV Plantalkaloidfluorouracil(5-FU) Efudex Cream,IV,topicalsolution Antimetabolitehydroxyurea Hydrea Capsule Antimetabolitelomustine(CCNU)† CeeNU Capsule Alkylatingmelphalan Alkeran IV Alkylatingmercaptopurine Purinethol Tablet Antimetabolitemethotrexate Rheumatrex IM,IV,tablet AntimetabolitemitomycinC Mutamycin IV Antibiotictemozolomide Temodar Capsule Antibioticthioguanine(6TG)* Tabloid Tablet Antimetabolitethiotepa * IV Alkylatingvalrubicin Valstar Injectionintothebladder Antimetabolitevinblastine Velban IV Plantalkaloidvincristine Oncovin IV Plantalkaloid
CYTOTOXIC CHEMOTHERAPY AGENTS
*Nolongeravailableasabrandeddrug.†BothTheJointCommissionandtheInstituteforSafeMedicationPracticesareagainstusingabbreviationsformedications;however,physiciansmaystillusetheseabbreviations.
Chapter 1 Pharmacology for Technicians 69
HORMONESMOA: InhibitsynthesisofadrenalsteroidsAdverse reactions: Hot flashes, transient tumor flare,headacheContraindication/caution: Pregnancy
GENERIC NAME BRAND NAME DOSAGE FORMS TARGET
aminoglutethimide * Tablet Breast,prostateanastrazole Arimidex Tablet Breastcancerexemestane Aromasin Tablet Breastcancerflutamide * Capsule Prostategoserelin Zoladex Implant,SC Prostate,endometriosis,
metastaticbreastcancerletrozole Femara Tablet Breastcancerleuprolide LupronDepot SC Prostatecarcinoma,endometriosismegestrol Megace Suspension,tablet Breast,endometriosistamoxifen * Tablet Breast
HORMONE AGENTS
*Nolongeravailableasabrandeddrug.
GENERIC NAME BRAND NAME DOSAGE FORMS ADVERSE EFFECTS
aldesleukin Proleukin IV Hypotension,diarrhea,feverorchillsinterferona-2a Roferon IM,IV,SC Weightloss,metallictaste,nausea,vomiting,abdominal
crampsinterferona-2b Intron IM,IV,SC Changesinmentalstatus,sorethroat,fever,fatigue,unusual
bleedinginterferonb-1a Avonex IM Myalgia,fever,chills,malaise,fatigueinterferonb-1b Betaseron SC Myalgia,fever,chills,malaise,fatigue
BIOLOGICAL RESPONSE MODIFIERS
GENERIC NAME BRAND NAME TREATMENT
bevacizumabinjection Avastin Treatmentofmetastaticcolorectaldiseasecetuximabinjection Erbitux Treatmentofmetastaticcolorectaldiseaseclofarabineinjection Clolar Treatmentofrelapsedorrefractorypediatricacutelymphoblastic
leukemiadasatinib Sprycel Treatmentforadultswithchronicmyeloidleukemiaerlotinib Tarceva Treatmentofadvancedandnon–smallcelllungcancerpanitumumab Vectibix Treatmentformetastaticcolorectalcarcinomapemetrexeddisodiuminjection Alimta Treatmentofmesotheliomaandnon–smallcelllungcancersorafenibtosylate Nexavar Treatmentofadvancedrenalcellcarcinomavorinostat Zolinza TreatmentofpatientswithcutaneousT-celllymphomasnelarabine Arranon TreatmentofT-celllymphoblasticleukemia
TARGETED ANTICANCER AGENTS
70 Mosby’s Review for the Pharmacy Technician Certification Examination
VITAMIN GENERIC NAME FUNCTIONS SOURCES
B1 Thiamine Coenzymeincarbohydratemetabolism;deficiencyresultsinberiberi
Pork,liver,kidney,wholecereal,grains,beans,andyeast
B2 Riboflavin Maintainsintegrityofmucousmembranesandmetabolicenergypathways
Milk,liver,kidney,cereals,andgreenvegetables
B3 Nicotinicacid Involvedinfatsynthesis,electrontransport,andproteinmetabolism;deficienciesresultindiar-rhea,dementia,anddermatitis;preventspellagra
Liver,yeast,leanmeats,peanuts,andbeans
B5 Pantothenicacid Deficienciesmayresultinfatigue,headache,sleepi-ness,nausea,GIpain,anddisturbancesofcoor-dination
Vegetables,cereals,yeast,andliver
B6 Pyridoxine Coenzymeinaminoacidandfattyacidmetabolism AllplantsandanimalsB9 Folicacid NeededfortheproductionofhealthyRBCs LiverandfreshgreenvegetablesB12 Cyanocobalamin IntrinsicfactorfortheproductionofRBCs;defi-
ciencyisseeninperniciousanemiaAnimaltissue
Biotin Deficiencyischaracterizedbydermatitisandanorexia
Yeast,eggyolk,vegetables,nuts,andcereals
C Ascorbicacid Maintainingnormalcellmembranepermeabilitypromoteswoundhealingandantiinflammatoryability;preventsscurvy
Greenplants,tomatoes,citrusfruits
EXAMPLES OF WATER-SOLUBLE VITAMINS
GI, Gastrointestinal;RBC,redbloodcell.
VITAMIN GENERIC NAME USES SOURCES
A Retinol Preventskeratomalacia Milk,butter,cheese,liver,andfishoilsD2 Ergocalciferol Preventsricketsinsmallchildrenandprevents
osteomalaciainadultsButter,milk,cheese,eggyolk,andfishoils
D3 CholecalciferolE Tocopherols Antioxidantforunsaturatedfattyacids;defi-
ciencyischaracterizedbyirritability,edema,andhemolyticanemia
Soybeanoil,wheatgerm,ricegerm,nuts,corn,butter,eggs,andleafygreenvegetables
K Phytonadione Formationofprothrombin Leafygreenvegetables,wheatbran,soybeans
EXAMPLES OF FAT-SOLUBLE VITAMINS
RefertoAppendixCforalistingofthetop200med-icationsprescribed.
VITAMINS, ELECTROLYTES, AND NUTRITIONAL SUPPLEMENTS
VITAMINS
Vitaminsareessentialorganicconstituentsfoundinmany food products and are necessary for normal
metabolicfunctions.Theymaybeeitherwatersolu-bleorfatsoluble.Fat-solublevitaminsaccumulateinlargestores,primarily in the liver.Deficienciesmayleadtodiseaseafterperiodsofrestrictedintake.Ex-cessive intake may result in toxicity. Water-solublevitamins are easily eliminated by the kidneys on adailybasis.
Chapter 1 Pharmacology for Technicians 71
MINERALS• Calcium: Needed for proper muscle and nerve
function;necessaryforproperboneandtoothfor-mation;preventionofosteoporosis
• Chromium:Aidsinmetabolismofsugars• Copper:Neededforproperbloodformation• Iodine:Neededforproperthyroidfunction• Iron:Neededforredbloodcellformation• Magnesium:Neededformusclefunction
• Potassium:Neededforheartandnerve function;cellularhomeostasis
• Sodium:Neededfornerveandmuscleformation;cellularhomeostasis
• Sulfur:Neededforenergyproductionandcellularfunction
• Zinc:NeededforproperimmunefunctionRefer to Appendix D for a listing of the commonvitamins.
HERBAL MEDICATIONS
NAME USES
Aloevera WoundandburnhealingAmericanginseng Energy,stress,immunesystembuilderBasil ReducinggasBilberry EyeandvasculardisordersBlackcohosh Menopause,premenstrualsyndrome,milddepression,arthritisCascarasagrada LaxativeCat’sclaw Antiinflammatory,antimicrobial,antioxidant,immunosupportiveCatniptea DiarrheaCayenne Eliminateschillsanddiscomfortfromcolds;promotesthehealingofulcersChamomile Calmingagent,sedativeChasteberry PremenstrualsyndromeChondroitin OsteoarthritisCinnamon Gas,diarrhea,upsetstomachCrampbark MenstrualcrampingCranberry UTIDandelion WaterretentionassociatedwithpremenstrualsyndromeDill GasandindigestionDongquai Anemia,energy(females),menopause,dysmenorrhea,premenstrualsyndromeEchinacea BoostsimmunesystemEveningprimroseoil PremenstrualsyndromeFennel StomachcrampsandgasFeverfew Headaches;prophylaxisformigraineGinger Antiemetic,antiinflammatory,GIdistressGlucosamine OsteoarthritisandrheumatoidarthritisGoldenseal BoostsimmunesystemGrapeseed Antioxidant,allergies,circulationGreentea Anticancer,antioxidant,lowerscholesterolHoptea SleepingaidIsoflavones Cancerprevention,decreasedboneloss,lowercholesterol,menopausalsymptomsKava ADD,ADHD,anxiety,sedationLomatium Antiviralagentfortheflu,immunostimulantLungwort URIMarshmallowroot Scratchythroat,ulcers,colitisMelatonin InsomniaMilkthistle Antioxidant,liverdiseasePanax Energy,stress,immunesystembuilderPassionflower TranquilizerPeppermint UpsetstomachSawpalmetto BenignprostatichyperplasiaSiberianginseng Athleticperformance,stress,immunebuilderSkullcap Tensionheadaches,irritabilityandanxietyassociatedwithpremenstrualsyndrome,stressSlipperyelmbark SorethroatSt.John’swort Depression,improvesimmunesystemValerian Sedative,analgesic,nervoustensionWhitewillowbark Aspirinsubstitute(analgesic,antipyretic,andantiinflammatory)Wildyam Femalevitality
ADD,Attention-deficitdisorder;ADHD,attention-deficithyperactivitydisorder;URI,upperrespiratoryinfection;UTI,urinarytractinfection.
72 Mosby’s Review for the Pharmacy Technician Certification Examination
RefertoAppendixEforalistingofthecommonOTCproducts.
Continued
OVER-THE-COUNTER MEDICATIONSBRAND NAME GENERIC NAME DRUG PROPERTIES
Actifed pseudoephedrineandtriprolidine Decongestant,antihistamineAdvil ibuprofen Analgesic,antipyretic,antiinflammatoryAfrin oxymetazoline DecongestantAleve naproxensodium Analgesic,antipyretic,antiinflammatoryAnbesol benzocaineandphenol TopicalanestheticAspercreme trolaminesalicylate TopicalanalgesicBayerAspirin aspirin Analgesic,antipyretic,antiinflammatoryBenadryl diphenhydramine AntihistamineBenylin diphenhydramine AntitussiveBetadine povidoneiodine TopicalantisepticBonine meclizine AntiemeticBufferin aspirin Analgesic,antipyretic,antiinflammatoryCaladryl pramoxine,camphor,andcalamine ProtectantCarmex menthol,camphor,alum,andsalicylicacid ProtectantCepastat phenol AnestheticChlor-Trimeton chlorpheniramine AntihistamineChloraseptic benzocaineandmenthol TopicalanestheticCitrucel methylcellulose LaxativeClaritin loratadine AntihistamineColace docusatesodium StoolsoftenerCompoundW salicylicacid KeratolyticCortaid hydrocortisone AntiinflammatoryDelsym dextromethorphan AntitussiveDimetapp brompheniramine AntihistamineanddecongestantDonnagel attapulgite AntidiarrhealDoxidan docusatecalcium StoolsoftenerDramamine dimenhydrinate AntiemeticDulcolax bisacodyl LaxativeDuoFilm salicylicacid KeratolyticEcotrin aspirin Analgesic,antipyretic,antiinflammatoryEmetrol phosphoratedcarbohydrates AntiemeticExcedrin acetaminophen,aspirin,andcaffeine Analgesic,antipyretic,antiinflammatoryFemstat-3 butoconazole AntifungalFibercon polycarbophil LaxativeGas-X simethicone AntiflatulentGaviscon aluminumhydroxideandmagnesiumtrisilicate AntacidGly-Oxide carbamideperoxide OralantisepticGyne-Lotrimin clotrimazole AntifungalImodiumAD loperamide AntidiarrhealIvyDry tannicacid,benzocaine,menthol,and
camphorAstringent
Kaopectate attapulgite AntidiarrhealLactinex Lactobacillus LactoseintoleranceListerine thymol,eucalyptol,methylsalicylate,and
mentholOralantiseptic
LotriminAF clotrimazole AntifungalMaalox aluminumhydroxideandmagnesium
hydroxideAntacid
Metamucil psylliumhydrophilicmucilloid LaxativeMicatin miconazole AntifungalMineralIce menthol TopicalmusclerelaxantMonistat miconazole AntifungalMotrinIB ibuprofen Analgesic,antipyretic,antiinflammatoryMotrin ibuprofen Analgesic,antipyretic,antiinflammatoryMylanta aluminumhydroxideandmagnesium
hydroxideAntacid
MylantaGas simethicone AntiflatulentMyliconDrops simethicone Antiflatulent
Chapter 1 Pharmacology for Technicians 73
BRAND NAME GENERIC NAME DRUG PROPERTIES
Myoflex trolaminesalicylate TopicalanalgesicNaphconA pheniramineandnaphazoline DecongestantNasalCrom cromolynsodium AntihistamineNeo-Synephrine phenylephrine DecongestantNeosporin polymyxinBsulfate,neomycin,and
bacitracinTopicalantibiotic
Nicoderm nicotinetransdermal SmokingcessationNicorette nicotinepolacrilex SmokingcessationNicotrol nicotinetransdermal SmokingcessationNix permethrin PediculusinfestationNoDoz caffeine CentralnervoussystemstimulantOcean normalsaline NasalmoisturizerOrabase-B benzocaine OralanestheticOrajel benzocaine OralanestheticOrudisKT ketoprofen Analgesic,antiinflammatoryOxy5,Oxy10 benzoylperoxide AcneagentPepcidAC famotidine AntiulcerPepto-Bismol bismuthsubsalicylate GastrointestinaldistressPercogesic phenyltoloxaminecitrateandacetaminophen AnalgesicPeri-Colace docusatesodiumandcasanthranol StoolsoftenerandlaxativePeroxyl hydrogenperoxide TopicalantisepticPhazyme simethicone AntiflatulentPhillipsMilkofMagnesia magnesiumhydroxide LaxativePrimateneMist epinephrine BronchodilatorRID pyrethrin PediculusinfestationRiopan hydroxymagnesiumandsimethicone AntacidRobitussin guaifenesin ExpectorantRogaine minoxidil HairreplacementSenokot sennaconcentrate LaxativeSominex diphenhydramine SleepSucrets hexylresorcinolanddyclonine OralanestheticSudafed pseudoephedrine DecongestantTagamet cimetidine AntiulcerTavist-D clemastinefumarateandpseudoephedrine Antihistamine,decongestantTearsNaturale hydroxypropylmethylcellulose LubricantTinactin tolnaftate AntifungalTums calciumcarbonate AntacidTylenol acetaminophen Analgesic,antipyreticZantac75 ranitidine AntiulcerZilactin tannicacid ColdsoresZostrix capsaicin Topicalmusclerelaxant
3. Whichofthefollowingmedicationsisindicatedforthetreatmentofdepression?a. Alprazolamb. Escitalopramc. Lorazepamd.Ramelteon
4. Which of the following is the generic name forSingulair?a. Albuterolb. Montelukastc. Theophyllined.Zileuton
CHAPTER 1 REVIEW QUESTIONS
1. Which of the following is not a condition fora medication to be considered therapeuticallyequivalent?a. Canbeadministeredbyanapprovedrouteb. Sameactiveingredientc. Samedosageformd.Samestrengthorconcentration
2. Whichof the following isanexampleofanACEinhibitor?a. Amlodipineb. Calanc. Corgardd.Vasotec
74 Mosby’s Review for the Pharmacy Technician Certification Examination
5. Whichofthefollowingisalong-actinginsulin?a. Insulinanaloginjectionb. Insulinglulisinec. Insulinglargined.Isophaneinsulin
6. WhichofthefollowingmedicationsisaffectedbyvitaminK?a. Clonidineb. Dabigatranc. Heparind.Warfarin
7. Which of the following medications must bemonitoredthroughabloodtest?a. Buspironeb. Hydroxyzinec. Levothyroxined.Pseudoephedrine
8. Which of the following suffixes indicates thedrugisabetablocker?a. -alolb. -ololc. -pamided.-pril
9. Which of the following medications is an ACEinhibitor used in the treatment of congestiveheartfailure?a. Capotenb. Cozaarc. Diovand.Zestoretic
10. Whichofthefollowingmedicationsmaybeusedinthetreatmentofinfluenza?a. Amantadineb. Acyclovirc. Penciclovird.Valacyclovir
11. Whichofthefollowingmedicationswilldiscolortheurine?a. Amoxicillinb. Oxybutyninc. Phenazopyridined.Tolterodine
12. Which of the following is a proton pumpinhibitor?a. Cimetidineb. Ranitidinec. Rabeprazoled.Sucralfate
13. Whichofthefollowingmedicationsisusedinthetreatmentofglaucoma?a. Ciprofloxacinb. Dexamethasonec. Latanoprostd.Naphazoline
14. Whichdrugclassificationwouldbeusedintreat-ingherpes?a. Antiviralb. Fusioninhibitorc. Nonnucleosidereversetranscriptaseinhibitord.Proteaseinhibitor
15. Which of the following medications is used toabortamigraineheadache?a. Aspirinb. Celecoxibc. Ibuprofend.Sumatriptan
16. Which of the following diuretics is often takenwithapotassiumsupplement?a. Amilorideb. Hydrochlorothiazidec. Spironolactoned.Triamterene
17. Which of the following hypoglycemic medica-tionsisclassifiedasabiguanide?a. Glipizideb. Glyburidec. Metformind.Repaglinide
18. Whichofthefollowingmedicationsifuseddur-ingpregnancymayresultinabirthdefect?a. Amoxicillinb. Clotrimazolec. Methyldopad.Tetracycline
19. Which of the following is the generic name forLexapro?a. Duloxetineb. Escitalopramc. Fluoxetined.Paroxetine
20. Which of the following OTC medications doesnotpossessesantiinflammatoryproperties?a. Acetaminophenb. Aspirinc. Ibuprofend.Naproxen
Chapter 1 Pharmacology for Technicians 75
21. Which of the following drug classifications willreducetheeffectivenessoforalcontraceptives?a. Antibioticsb. Anticonvulsantsc. Antifungalsd.Alloftheabove
22. Which of the following is the generic name forPlavix?a. Clopidogrelb. Enoxaparinc. Heparind.Warfarin
23. ForwhichofthefollowingconditionsisJanuviaindicated?a. Chronicobstructivepulmonarydiseaseb. Congestiveheartfailurec. Diabetesd.Herpes
24. Whichmedicationisthedrugofchoiceforacar-diacarrhythmia?a. Digoxinb. Furosemidec. Lisinoprild.Triamterene
25. Whichof the followingantibiotics if takenwithdairyproductsorantacidswillresultinareduc-tionofitseffectiveness?a. Amoxicillinb. Cephalexinc. Erythromycind.Tetracycline
26. Which of the following is the generic name forDiovan?a. Irbesartanb. Losartanc. Olmesartand.Valsartan
27. Whichofthefollowingmedicationsisaproteaseinhibitor?a. Combivirb. Epivirc. Kaletrad.Trizivir
28. Whichofthefollowingmedicationsisindicatedinthetreatmentofangina?a. Isosorbidedinitrateb. Isosorbidemononitratec. Nitroglycerind.Alloftheabove
29. Which of the following is the brand name foripratropium–albuterol?a. Combiventb. Combivirc. Compazined.Synercid
30. Whichofthefollowingmedicationsisindicatedinthetreatmentofbipolardisease?a. Amitriptylineb. Imipraminec. Lithiumd.Pregabalin
31. Which of the following drug classificationsshouldbetakenwithfoodormilktoavoidstom-achdistress?a. Beta-blockersb. Cephalosporinsc. NSAIDsd.Protonpumpinhibitors
32. Whichofthefollowingmedicationsmustbeiniti-atedinahospital?a. Amiodaroneb. Bretylliumc. Dronedaroned.Sotalol
33. Tyramine-containingfoodsandwinesshouldbeavoidedifapatientistakingwhichofthefollow-ingdrugclassifications?a. Cephalosporinsb. COX-2inhibitorsc. Monoamineoxidaseinhibitorsd.NSAIDs
34. Whichof the followingmedications isnot indi-catedforhypothyroidism?a. Levothyroxineb. Liothyroninec. Liotrixd.Methimazole
35. Which of the following vitamins is not watersoluble?a. B2
b. Biotinc. Cd.D3
76 Mosby’s Review for the Pharmacy Technician Certification Examination
36. Whichofthefollowingmedicationsisindicatedforinsomnia?a. Etodolacb. Ibuprofenc. Valproicacidd.Zolpidem
37. Whichof the followingherbalproductsmaybeusedasalaxative?a. Cascarasagradab. Chondroitinc. Cranberryd.Glucosamine
38. Whichofthefollowingisclassifiedasahormoneagentusedaschemotherapyagent?a. Cisplatinb. Etoposidec. Interferona-2ad.Tamoxifen
39. Which of the following topical preparations isindicatedforacnevulgaris?a. Ciclopiroxb. Miconazolec. Tolnaftated.Isotretinoin
40. Whichofthefollowingglaucomaagentsmustberefrigerated?a. Brimonidineb. Latanoprostc. Timolold.Travoprost
41. Whichofthefollowingfoodsprovide(s)asourceofvitaminC?a. Cerealsb. Eggyolkc. Liverd.Tomatoes
42. WhichofthefollowingisnotanNSAID?a. Diclofenacb. Ibuprofenc. Meperidined.Piroxicam
43. Whichofthefollowingmedicationsisanexam-ple of a disease-modifying antirheumatic drug(DMARD)?a. Enbrelb. Humirac. Orenciad.Alloftheabove
44. Whichofthemedicationsisindicatedinthetreat-mentofpsoriasis?a. Adapaleneb. Azelaicacidc. Calcipotriened.Fluorouracil
45. Which of the following is the generic name forGlucovance?a. Glipizide–metforminb. Glyburide–metforminc. Pioglitazoned.Repaglinide
46. Which of the following is the generic name forSeroquel?a. Aripripazoleb. Magnesiumc. Olanzapined.Quetiapine
47. Whichofthefollowingdrugclassificationsisnotindicatedinthetreatmentofdepression?a. Benzodiazepinesb. Monoamineoxidaseinhibitorsc. Selectiveserotoninreuptakeinhibitorsd.Tricyclicantidepressants
48. WhichofthefollowingmedicationsindicatedforADHDisnotacontrolledsubstance?a. Adderallb. Cylertc. Ritalind.Strattera
49. WhatisthegenericnameforViagra?a. Sildenafilb. Selegilenec. Tadalafild.Vardenafil
50. Whichofthefollowingisasideeffectofalumi-numhydroxide?a. Constipationb. Diarrheac. Electrolyteimbalanced.Metallictaste
51. Which of the following is true when takingFosamax?a. Liedownaftertakingthemedicine.b. Takethemedicineatbedtime.c. Takewithfood.d.Takewithwater.
Chapter 1 Pharmacology for Technicians 77
52. To which drug classification does furosemidebelong?a. Beta-blockerb. Calciumchannelblockerc. HMGCOAreductaseinhibitord.Loopdiuretic
53. WhatisthegenericnameforLyrica?a. Divalproexb. Gabapentinc. Pregabalind.Primidone
54. Which of the following medications should betakenwithfood?a. Latanoprostb. Ondansetronc. Prednisoned.Timolol
55. Whichofthefollowingmedicationsmayresultindrowsinessasasideeffect?a. Benadrylb. Caltratec. Sudafedd.Tylenol
56. Which of the following is the brand name forsimvastatin?a. Crestorb. Mevacorc. Zetiad.Zocor
57. Which of the following is the generic name forNasonex?a. Budesonideb. Fluticasonec. Momentasoned.Triamcinolone
58. Whatdoesthe“HCT”representinBenicarHCT?a. Hydralazineb. Hydrochlorothiazidec. Hydrocodoned.Hydrocortisone
59. Whichofthefollowingmedicationswouldnotbeusedtotreathyperthyroiddisease?a. Levothyroxineb. Medroxyprogesteronec. Mmethimazoled.Zolmitriptan
60. Which of the following medications affects theclottingofplatelets?a. Clopidogrelb. Enoxaparinc. Heparind.Warfarin
61. Whatisthebrandnameforamoxicillintrihydrate–potassiumclavulanate?a. Augmentinb. Ceftinc. Ciprod.Ketek
62. Which of the following medications is used totreatbacterialinfections?a. Acyclovirb. Cephalexinc. Clotrimazoled.Stavudine
63. Whichofthefollowingagentsisanexpectorant?a. Guaifenesinb. Cetrizinec. Loratadined.Oxymetazoline
64. Which of the following medications could beusedtotreatanxiety?a. Alprazolamb. Carbamazepinec. Cephalexind.Valproicacid
65. What electrolyte does Klor-Con provide to thebody?a. Calciumb. Magnesiumc. Potassiumd.Sodium
66. ForwhatconditionisActonelindicated?a. Acnevulgarisb. Arrhythmiac. Osteoporosisd.Parasites
67. WhatistheactiveingredientinTylenol?a. Acetaminophenb. Aspirinc. Ibuprofend.Naproxen
78 Mosby’s Review for the Pharmacy Technician Certification Examination
68. WhatisthegenericnameforFlomax?a. Doxazosinb. Dutasteridec. Tamsulosind.Terazosin
69. Whichofthefollowingvitaminsisfatsoluble?a. Ab. B1
c. B6
d.C
70. Whichofthefollowingpregnancycategoriesin-dicatesthatadequatestudiesinpregnantwomenhave failed to showa risk to fetuses in thefirsttrimesterandthereisnoevidenceofriskinlatertrimesters?a. CategoryAb. CategoryBc. CategoryCd.CategoryD
71. WhatisthegenericnameforDetrolLA?a. Flutamideb. Prazosinc. Terazosind.Tolterodine
72. Whichofthefollowingmedicationsisindicatedtotreatbipolardiseaseandepilepsy?a. Carbamazepineb. Lithiumc. Olanzapine–fluoxetined.Risperidone
73. TowhichdrugclassificationdoesSingulairbelong?a. Antihistamineb. Bronchodilatorc. Leukotrieneinhibitord.Xanthinederivative
74. Whichofthefollowingmedicationsisindicatedforarrhythmias?a. Cogentinb. Multaqc. Seroqueld.Zerit
75. WhatisthegenericnameforAricept?a. Donepezilb. Memantinec. Rivastigmined.Tacrine